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A B S T R A C T
Background
Surgical resection is the only potentially curative treatment for pancreatic and periampullary cancer. A considerable proportion of
patients undergo unnecessary laparotomy because of underestimation of the extent of the cancer on computed tomography (CT)
scanning. Laparoscopy can detect metastases not visualised on CT scanning, enabling better assessment of the spread of cancer (staging
of cancer). This is an update to a previous Cochrane Review published in 2013 evaluating the role of diagnostic laparoscopy in assessing
the resectability with curative intent in people with pancreatic and periampullary cancer.
Objectives
To determine the diagnostic accuracy of diagnostic laparoscopy performed as an add-on test to CT scanning in the assessment of
curative resectability in pancreatic and periampullary cancer.
Search methods
We searched the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE via PubMed, EMBASE via OvidSP (from
inception to 15 May 2016), and Science Citation Index Expanded (from 1980 to 15 May 2016).
Selection criteria
We included diagnostic accuracy studies of diagnostic laparoscopy in people with potentially resectable pancreatic and periampullary
cancer on CT scan, where confirmation of liver or peritoneal involvement was by histopathological examination of suspicious (liver or
peritoneal) lesions obtained at diagnostic laparoscopy or laparotomy. We accepted any criteria of resectability used in the studies. We
included studies irrespective of language, publication status, or study design (prospective or retrospective). We excluded case-control
studies.
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Data collection and analysis
Two review authors independently performed data extraction and quality assessment using the QUADAS-2 tool. The specificity of
diagnostic laparoscopy in all studies was 1 because there were no false positives since laparoscopy and the reference standard are one
and the same if histological examination after diagnostic laparoscopy is positive. The sensitivities were therefore meta-analysed using a
univariate random-effects logistic regression model. The probability of unresectability in people who had a negative laparoscopy (post-
test probability for people with a negative test result) was calculated using the median probability of unresectability (pre-test probability)
from the included studies, and the negative likelihood ratio derived from the model (specificity of 1 assumed). The difference between
the pre-test and post-test probabilities gave the overall added value of diagnostic laparoscopy compared to the standard practice of CT
scan staging alone.
Main results
We included 16 studies with a total of 1146 participants in the meta-analysis. Only one study including 52 participants had a low risk
of bias and low applicability concern in the patient selection domain. The median pre-test probability of unresectable disease after CT
scanning across studies was 41.4% (that is 41 out of 100 participants who had resectable cancer after CT scan were found to have
unresectable disease on laparotomy). The summary sensitivity of diagnostic laparoscopy was 64.4% (95% confidence interval (CI)
50.1% to 76.6%). Assuming a pre-test probability of 41.4%, the post-test probability of unresectable disease for participants with a
negative test result was 0.20 (95% CI 0.15 to 0.27). This indicates that if a person is said to have resectable disease after diagnostic
laparoscopy and CT scan, there is a 20% probability that their cancer will be unresectable compared to a 41% probability for those
receiving CT alone.
A subgroup analysis of people with pancreatic cancer gave a summary sensitivity of 67.9% (95% CI 41.1% to 86.5%). The post-test
probability of unresectable disease after being considered resectable on both CT and diagnostic laparoscopy was 18% compared to
40.0% for those receiving CT alone.
Authors’ conclusions
Diagnostic laparoscopy may decrease the rate of unnecessary laparotomy in people with pancreatic and periampullary cancer found
to have resectable disease on CT scan. On average, using diagnostic laparoscopy with biopsy and histopathological confirmation of
suspicious lesions prior to laparotomy would avoid 21 unnecessary laparotomies in 100 people in whom resection of cancer with
curative intent is planned.
P L A I N L A N G U A G E S U M M A R Y
What is the diagnostic accuracy of laparoscopic staging following a CT scan for assessing whether pancreatic and periampullary
cancer is resectable?
Background
The pancreas is an organ situated in the abdomen close to the junction of the stomach and small bowel. It secretes digestive juices
which are necessary for the digestion of all food materials. The digestive juices secreted in the pancreas drain into the upper part of the
small bowel via the pancreatic duct. The bile duct is a tube which drains bile from the liver and gallbladder. The pancreatic and bile
ducts share a common path just before they drain into the small bowel. This area is called the periampullary region. Surgical removal
is the only potentially curative treatment for cancers arising from the pancreatic and periampullary regions. A considerable proportion
of patients undergo unnecessary major open abdominal exploratory operation (laparotomy) because their CT scan has underestimated
the spread of cancer. If during the major open operation the cancer is found to have spread within the abdomen, patients are referred
for alternate treatments such as chemotherapy, which do not cure the cancer but may improve survival.
This major open abdominal operation can be avoided if the spread of cancer within the abdomen is known, called ’staging’ the cancer.
The minimum test used for staging is usually the computed tomography (CT) scan. However, CT scan can understage the cancer,
that is it can underestimate the spread of cancer. Laparoscopy, a procedure whereby a small telescope is inserted inside the abdomen
through a small (keyhole) surgical incision, can detect spread not identified on CT scanning. Different studies report different accuracy
of laparoscopy in assessing whether the cancer can be removed. Our aim therefore was to find out the average diagnostic accuracy of
laparoscopy for staging pancreatic and periampullary cancers considered to be removable after a CT scan. This review is an update of
our previous review.
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A glossary of terms is provided in Appendix 1.
Study characteristics
We performed a thorough literature search to identify studies published up to 15 May 2016. We identified 16 studies reporting
informationon1146peoplewith pancreatic or periampullary cancerswhichwere considered to be eligible for potentially curative surgery
based on CT scan staging. These studies evaluated diagnostic laparoscopy and compared results of the procedure with the eventual
diagnosis by the surgeon that the cancer was not resectable during major abdominal operation or examination under microscope.
Quality of evidence
All of the studies were of unclear or low methodological quality in one or more aspects, which may undermine the validity of our
findings.
Key results
Of those people with what CT suggests seems to be a potentially surgically curable cancer, the percentage in whom more extensive
cancer was found on further staging with diagnostic laparoscopy or laparotomy ranged between 17% and 82% across studies. The
median percentage of people in whom cancer spread was not detected by CT scan was 41%. Adding staging laparoscopy to CT scan
might decrease the number of people with unremovable disease undergoing unnecessary major operations to 20% compared to those
who undergo unnecessary major operation after CT scan alone (41%). This means that using diagnostic laparoscopy could halve the
rate of unnecessary major open operations in people undergoing major surgery for potentially surgically curable pancreatic cancer.
B A C K G R O U N D
Periampullary cancer develops near the ampulla of Vater (National
Cancer Institute 2011a). This includes cancer of the head and neck
of the pancreas, cancer of the distal end of the bile duct, cancer of
the ampulla of Vater, and cancer of the second part of the duode-
num. Pancreaticoduodenectomy is themain treatment for cancers
arising in the head of the pancreas, ampulla, and second part of
the duodenum. Surgical resection is generally considered to be the
only cure for pancreatic cancer. However, only 15% to 20% of
people with pancreatic cancers undergo potentially curative resec-
tion (Conlon 1996; Engelken 2003; Michelassi 1989; Shahrudin
1997; Smith 2008). In all other people, the cancers are not resected
because of infiltration of local structures, disseminated disease,
or because the person is deemed unfit to undergo major surgery.
Computed tomography (CT scan) is generally used for staging
pancreatic and periampullary cancers (National Cancer Institute
2011b). Despite undergoing routine CT scanning to stage the dis-
ease (Mayo 2009), a substantial proportion of patients (approx-
imately 10% to 25%) undergo unnecessary laparotomy (open-
ing the abdomen using a large incision) with lack of curative re-
sectability identified only during the laparotomy (Lillemoe 1999;
Mayo 2009). Laparoscopy can be used to detect metastatic disease
in people with periampullary cancer.
Target condition being diagnosed
Inability to perform curative resectability of pancreatic and peri-
ampullary cancer (’unresectable’ cancers)
Index test(s)
Diagnostic laparoscopy involves the use of a laparoscope (a tele-
scope inserted into the abdominal cavity through a keyhole inci-
sion) to visualise and explore the abdominal organs. Also known
as staging laparoscopy, it is used following initial staging by CT
scanning. Any spread of cancer to the liver, peritoneum, or adja-
cent structures can be visualised during diagnostic laparoscopy. A
biopsy of the suspicious lesion can be performed, and the biopsy
specimen can be examined under the microscope to confirm that
the suspicious lesion is spread of cancer.
Clinical pathway
No standard algorithm is currently available for assessing the re-
sectability of pancreatic and periampullary cancers, with clinicians
following their own algorithms based on either their clinical expe-
rience or education. Almost all current algorithms include a CT
scan as one of the tests (National Cancer Institute 2011b). CTmay
be the only test performed before laparotomy. Other tests such
as diagnostic laparoscopy, positron emission tomography (PET)
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scanning, magnetic resonance imaging (MRI), or endoscopic ul-
trasound (EUS) may be used in addition to CT scan to assess
resectability. The possible clinical pathway in the staging of pan-
creatic cancers is shown in Figure 1. Another review is assessing
the accuracy of these various tests and CT scanning (Gurusamy
2015).
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Figure 1. Clinical pathway.EUS: endoscopic ultrasoundMRI: magnetic resonance imagingPET: positron
emission tomography
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Prior test(s)
The minimum prior test should be CT, and the cancer should be
resectable with curative intent on the basis of the CT scan to be
included in this review. Other tests such as PET scanning, MRI,
or EUS might be used in addition to CT scanning to assess re-
sectability prior to diagnostic laparoscopy. We included partici-
pants in this review irrespective of whether they underwent these
other tests prior to diagnostic laparoscopy.
Role of index test(s)
Diagnostic laparoscopy can be considered as an add-on test to the
CT scan prior to laparotomy done with the intention of perform-
ing a potentially curative resection.
Alternative test(s)
Other tests such as PET scanning, laparoscopic ultrasound, or EUS
may be used as alternative tests to diagnostic laparoscopy in people
considered to have CT resectable pancreatic and periampullary
cancer. As mentioned earlier, PET scanning and EUS may also
be used prior to diagnostic laparoscopy. Laparoscopic ultrasound
may be used in combination with diagnostic laparoscopy, and the
strategy for determining test positivity of the combination may be
either test positive or both tests positive.
Rationale
Diagnostic laparoscopy allows internal visualisation of the ab-
domen and can detect any peritoneal spread of the cancer or the in-
volvement of any adjacent structures. A biopsy and histopatholog-
ical examination of any suspicious lesion can be performed and an
unnecessary laparotomy to attempt curative resection avoided. If
this add-on test can identify unresectable cancers without laparo-
tomy, it might decrease the costs and morbidity associated with
unnecessary laparotomy. This is an update to an earlier Cochrane
Review assessing the resectability with curative intent in pancre-
atic and periampullary cancer published in 2013 (Allen 2013).
O B J E C T I V E S
To determine the diagnostic accuracy of diagnostic laparoscopy
performed as an add-on test to CT scanning in the assessment of
curative resectability in pancreatic and periampullary cancer.
Secondary objectives
We planned to explore the following sources of heterogeneity.
1. Studies at low risk of bias versus those at unclear or high
risk of bias based on methodological quality assessment using the
QUADAS-2 tool (Whiting 2011).
2. Full-text publications versus abstracts (this can inform
about publication bias since there may be an association between
the results of the study and the study reaching full publication
status) (Eloubeidi 2001).
3. Prospective studies versus retrospective studies.
4. Proportion of participants with pancreatic cancer,
ampullary cancer, and bile duct cancers (although classified as
periampullary cancers, each has a different prognosis)
(Klempnauer 1995). The additional value of diagnostic
laparoscopy may be different because of the extent of spread in
these different types of periampullary cancers.
5. Procedures performed under the same anaesthetic versus
procedures performed under a different anaesthetic (there are
likely to be differences in the histopathological examinations
since the former procedure is associated with frozen section
biopsy, while the latter procedure is likely to be associated with
paraffin section). Paraffin section is considered to be the gold
standard in identifying cancer. Frozen sections can be associated
with false-negative results (Yeo 2002). However, frozen section
results are always confirmed by paraffin section histological
examinations.
6. Different definitions for resectable cancer on laparotomy.
Different surgeons may consider cancer unresectable differently,
i.e. they will have different criteria for unresectability on
laparotomy (other than the consensus criteria for resectability).
For example, one surgeon may judge that the cancer is
unresectable on laparotomy because of the involvement of the
vessel and consider the reference standard to be positive. This
will result in a false-negative result for laparoscopy. Another
surgeon may judge the same cancer to be resectable despite the
involvement of the vessel and proceed with resection. The
reference standard will be negative in this situation, resulting in a
true-negative result for laparoscopy. This might have an intrinsic
threshold effect.
7. Additional pre-tests performed (besides CT scan). This can
alter the pre-test probability of unresectability and can help in
the assessment of the additional value of diagnostic laparoscopy
under various situations.
M E T H O D S
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Criteria for considering studies for this review
Types of studies
We included studies that evaluated the accuracy of diagnostic la-
paroscopy in the appropriate patient population (see below) irre-
spective of language or publication status, or whether data were
collected prospectively or retrospectively. However, we excluded
case reports which did not provide sufficient diagnostic test accu-
racy data. We also excluded case-control studies, which are prone
to bias (Whiting 2011).
Participants
People about to undergo curative resection for pancreatic and pe-
riampullary cancer with no contraindications (such as metastatic
disease) for curative resection on CT scan, and who were anaes-
thetically fit to undergo major surgery.
Index tests
We included only diagnostic laparoscopy in which histopatholog-
ical confirmation of metastatic spread was obtained on a paraffin
section.
Target conditions
The target conditions were unresectable pancreatic and peri-
ampullary cancers, that is diagnostic laparoscopy was considered
to be a positive test if the pancreatic or periampullary cancer was
unresectable. In these cancers it is not possible to perform cura-
tive resectability. There are no uniform criteria for resectability
of pancreatic and periampullary cancer. Consensus exists for the
definition of borderline resectable cancers (Abrams 2009). There-
fore, where there is less tissue involvement than in a borderline
resectable cancer, the tumour can be considered as resectable. We
accepted any criteria of resectability used by the study authors and
acknowledge that this could potentially create a threshold effect.
In general, the cancer would not be resected if liver or peritoneal
metastases were noted, or if the cancer had invaded important
adjacent blood vessels that are beyond the criteria for borderline
resectable cancers, for example greater than 180° involvement of
the superior mesenteric artery.
Reference standards
Confirmation of liver or peritoneal involvement by histopatholog-
ical examination of suspicious (liver or peritoneal) lesions obtained
at diagnostic laparoscopy or laparotomy. We accepted only paraf-
fin section histology as the reference standard. In clinical practice,
depending on the urgency of the results, a frozen section biopsy
may be done to obtain immediate results. However, this is always
confirmed by subsequent paraffin section histology (which can
take several days) because frozen section biopsy is not as reliable as
paraffin section histology. We also accepted the surgeon’s judge-
ment of unresectability at laparotomy when biopsy confirmation
was not possible. For example, if the tumour has invaded the adja-
cent blood vessels the surgeon may not resect the tumour because
of the danger posed by resecting part of a large blood vessel, and
so biopsy confirmation cannot be obtained.
Diagnostic laparoscopy results versus reference standard
results
A schematic diagram of the results of diagnostic laparoscopy
against those of histopathology or laparotomy is shown in Figure
2. Positive histopathology of a biopsy taken during diagnostic la-
paroscopy confirms the presence of cancer (true positive). Thus,
the index test and the reference standard are one and the same if
there is positive histopathology after laparoscopy. As a result, false
positives are not possible, and there is no sampling error associ-
ated with specificity because it is by definition equal to 1. If the
histopathology is negative, the surgeon will perform a laparotomy.
The cancer may be resectable with curative intent (true negative)
or may not be resectable with curative intent (false negative) based
on histopathological confirmation or the surgeon’s judgement of
unresectability on laparotomy if biopsy confirmation cannot be
obtained.
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Figure 2. Schematic diagram indicating how true-positive, false-negative, and true-negative test results
were determined.
Search methods for identification of studies
We included all studies irrespective of language of publication and
publication status. We obtained translations of any non-English
articles.
Electronic searches
We searched the following databases until 15 May 2016.
1. Cochrane Central Register of Controlled Trials
(CENTRAL) in the Cochrane Library (Issue 5, 2016) (Appendix
2).
2. MEDLINE via PubMed (January 1946 to May 2016)
(Appendix 3).
3. EMBASE via OvidSP (January 1947 to May 2016)
(Appendix 4).
4. Science Citation Index Expanded (January 1980 to May
2016) (Appendix 5).
Searching other resources
We searched the references of the included studies to identify addi-
tional studies. We also searched for articles related to the included
studies by performing the ’related search’ function in MEDLINE
(PubMed) and EMBASE (OvidSP) and a ’citing reference’ search
(by searching the articles which cited the included articles) in Sci-
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ence Citation Index Expanded and EMBASE (OvidSP) (Sampson
2008).
Data collection and analysis
Selection of studies
Two review authors (VA and KG or AK) independently searched
the references to identify relevant studies. We obtained the full
texts for references considered relevant by at least one of the review
authors. Two review authors screened the full-text papers against
the inclusion criteria. Any differences in study selection were ar-
bitrated by BRD.
Data extraction and management
Two review authors independently extracted the following data
from each included study, resolving any differences by discussion
with BRD.
• First author.
• Year of publication.
• Study design (prospective or retrospective; cross-sectional
studies or randomised clinical trials).
• Inclusion and exclusion criteria for individual studies.
• Total number of participants.
• Number of females.
• Average age of the participants.
• Type of cancer (i.e. head and neck of pancreas, body and
tail of pancreas, ampullary cancers, cancer of the lower end of the
bile duct).
• Criteria for unresectability at diagnostic laparoscopy (index
test) and at laparotomy (reference standard).
• Preoperative tests carried out prior to diagnostic
laparoscopy.
• Description of the index test.
• Reference standard.
• Number of true positives, true negatives, and false negatives.
• Complications of diagnostic laparoscopy.
The unit of analysis was the participant, meaning that if multiple
metastases were found in a participant with a negative index test,
the number of false negatives was considered to be one. This is
because it is the presence rather than the number of metastases
which is important in determining the curative resectability of pa-
tients. We considered participants with uninterpretable diagnostic
laparoscopy results (nomatter the reason given for lack of interpre-
tation) as negative for the test since in clinical practice laparotomy
would be carried out on these patients. However, we included such
participants in the analysis only if the results of laparotomy were
available. We sought further information from study authors if
necessary.
Assessment of methodological quality
Two review authors (VA and KG) independently assessed study
quality using the QUADAS-2 assessment tool (Whiting 2011).
Any differences were resolved by BRD. The criteria used to classify
the different studies are shown in Table 1. We considered studies
which were classified as ’low risk of bias’ and ’low concern’ in all
the domains as having high methodological quality.
Statistical analysis and data synthesis
The index test used was diagnostic laparoscopy with biopsy and
histopathological confirmation. For the reason mentioned ear-
lier, false positives were not possible. We therefore performed
meta-analysis of only sensitivities by using a univariate random-
effects logistic regression model. The analysis was done using the
NLMIXEDprocedure in SAS version 9.2 (SAS Institute Inc, Cary,
North Carolina, USA) (Appendix 6). We used the ESTIMATE
statement inNLMIXED to obtain the negative likelihood ratio by
using a function of the estimated summary sensitivity and a speci-
ficity of 1. The median pre-test probability of unresectability was
calculated from the pre-test probabilities of the included studies.
We calculated the proportion of participants classified as having
resectable disease by CT scanning and diagnostic laparoscopy who
were actually found to be unresectable at laparotomy (post-test
probability) using themedian pre-test probability and the negative
likelihood ratio (see Appendix 7 for details). The difference in the
unresectability proportions (post-test probability minus pre-test
probability) gave the overall added value of diagnostic laparoscopy
compared to the standard practice of CT scan staging alone.
Investigations of heterogeneity
Weplanned to explore heterogeneity by using the different sources
of heterogeneity as covariate(s) in the regression model. However,
this was not possible because the information was either not avail-
able or was the same in all the studies.
Sensitivity analyses
We did not plan any sensitivity analyses.
R E S U L T S
Results of the search
We identified a total of 14,254 references through the electronic
searches of the Cochrane Upper Gastrointestinal and Pancreatic
Diseases Group Controlled Trials Register and CENTRAL (n =
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191), MEDLINE (n = 5228), EMBASE (n = 4460), and Sci-
ence Citation Index (n = 4375). Figure 3 shows the flow of ref-
erences through the selection process. We excluded 7264 dupli-
cates and clearly irrelevant references through reading the abstracts.
We retrieved 213 references for further assessment. We identified
no references through scanning reference lists of the identified
studies. Of the 213 references, we excluded 194 for the reasons
listed in the Characteristics of excluded studies table. In one study
(Hashimoto 2015), all 11 participants who underwent diagnos-
tic laparoscopy and laparotomy had resectable pancreatic cancers.
There were therefore no true positives and false negatives for esti-
mation of sensitivity, and we excluded this study from the review.
We included 18 references of 16 studies.
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Figure 3. Flow diagram of study selection.
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Methodological quality of included studies
The methodological quality of the included studies is shown in
the Characteristics of included studies table, Figure 4, and Figure
5.
Figure 4. Risk of bias and applicability concerns graph: review authors’ judgements about each domain
presented as percentages across included studies.
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Figure 5. Risk of bias and applicability concerns summary: review authors’ judgements about each domain
for each included study.
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There was a high risk of bias regarding the selection of par-
ticipants in most studies (Ahmed 2006; Arnold 1999; Arnold
2001a; Beenen 2014; Brooks 2002; Contreras 2009; John 1995;
Kishiwada 2002; Lavy 2012; Menack 2001; Merchant 1998;
Reddy 1999; Reed 1997; Shah 2008; Warshaw 1986). This was
because the studies did not explicitly state whether a consecutive
or random sample of patients was recruited or whether they had
made inappropriate exclusions. Only one study had low risk of
bias and low applicability concerns regarding the selection of par-
ticipants (Fernandez-Castillo 1995).
There were no risk of bias issues or concerns regarding applicability
of the index test in any of the studies, as was anticipated (Table 1).
As anticipated, it proved impossible to determine whether an ap-
propriate reference standard was used. This is because even in the
presence of predefined criteria for unresectability, it may not be
ethical to biopsy and confirm that the tumour has invaded the
blood vessels because of the risk of major bleeding. Thus it was not
possible to determine whether the cancer was truly unresectable.
None of the studies reported whether the margins of the resected
lesions were clear of cancer. It was therefore not possible to deter-
mine whether the cancer was truly resectable with curative intent.
None of the studies reported the time interval between diagnostic
laparoscopy and laparotomy. In addition, many studies had ex-
cluded some patients inappropriately. All of the studies were there-
fore at unclear or high risk of bias in the flow and timing domain.
Findings
All of the included studies assessed pancreatic or periampullary
cancer. The 16 included studies involved a total of 1146 partici-
pants (Data and analyses). The age of participants in the included
studies ranged between 15 and 87 years. Studies that provided de-
mographic details of participants reported roughly equal numbers
of males and females. Seven studies included only people with
pancreatic cancer (Ahmed 2006; Arnold 2001a; Contreras 2009;
Fernandez-Castillo 1995; Kishiwada 2002; Lavy 2012; Warshaw
1986), and two studies included only people with periampullary
malignancies (Beenen 2014; Brooks 2002). The remaining studies
did not provide information regarding the specific type of cancer
they considered.
The details of the CT scan; other tests the participants underwent
in addition to the CT scan; probability of CT resectable disease
identified as unresectable by diagnostic laparoscopy or laparotomy
(pre-test probability); reasons for CT resectable disease identified
as unresectable by diagnostic laparoscopy; probability of CT and
diagnostic laparoscopy resectable disease identified as unresectable
at laparotomy (post-test probability); and the reasons for CT and
diagnostic laparoscopy resectable disease identified as unresectable
at laparotomy are all shown in Table 2.
The pre-test probability of unresectability (due to distant metas-
tases or local infiltration) after CT scanning ranged from 17.4%
to 82% in the included studies. The median pre-test probability
was 41.4%, meaning that a person that was said to be resectable
on CT scanning still had a 41.4% chance that their cancer would
be unresectable. Visual inspection of the data in Table 2 did not
suggest a relationship between the type of CT scan (such as he-
lical CT or multi-detector row CT, with or without a pancreatic
protocol) or date of publication and the pre-test probability of
unresectable disease.
The summary estimate of sensitivity was 64.4% (95% confidence
interval (CI) 50.1 to 76.6), and the summary negative likelihood
ratio was 0.36 (95% CI 0.24 to 0.52). Using the median pre-test
probability of unresectable disease of 0.414, the post-test proba-
bility of unresectable disease for participants with a negative test
result was 0.20 (95% CI 0.15 to 0.27). This means that if a per-
son is said to have resectable disease after diagnostic laparoscopy
(and a CT scan), there is a 20% chance that their cancer will be
unresectable. The post-test probability of unresectable disease is
shown at different pre-test probabilities of unresectable disease in
Figure 6.
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Figure 6. Post-test probability of unresectability for various pre-test probabilities.
None of the studies reported any complications related to di-
agnostic laparoscopy. In some instances diagnostic laparoscopy
provided an inconclusive result, that is it was unclear whether
the participant had resectable or unresectable disease. Eight stud-
ies reported drop-out rates of: 37.3% (Ahmed 2006), 29.8%
(Arnold 1999), 36.1% (Beenen 2014), 67.5% (Contreras 2009),
4.4% (Fernandez-Castillo 1995), 10.6% (Merchant 1998), 1.0%
(Reddy 1999), and 61.2% (Shah 2008). In four of these stud-
ies the participants underwent laparotomy directly (Ahmed 2006;
Beenen 2014; Contreras 2009; Shah 2008), and there was no in-
dication of the selection criteria used for participants who had di-
agnostic laparoscopy. The other studies did not report drop-out
rates.
A subgroup analysis of studies that included only participants with
pancreatic cancer gave a summary sensitivity of 67.9% (95% CI
41.1% to 86.5%). The summary negative likelihood ratio was
0.32 (95% CI 0.15 to 0.68). The median pre-test probability
of unresectability was 40.0% in this subgroup of studies. Using
this pre-test probability, the post-test probability of unresectable
disease after negative diagnostic laparoscopy was 0.18 (95% CI
0.31 to 0.92).
We also performed a post hocmeta-regression of studies published
before and after the year 2000, to test whether the sensitivity of
diagnostic laparoscopy was different in the last decade, because
major technological innovations in CT scans such as helical CT
scans and multi-slice CT scans became widely available in the last
decade. The likelihood ratio test comparing the model with and
without this covariate gave a P value of 1.0, indicating no evidence
of a statistically significant difference in sensitivity between studies
published before or after the year 2000.
We found an inconsistency in one study between the results re-
ported in the main text of the study and a flow diagram which
summarised the results (Kishiwada 2002). In our previous review
we investigated the effect of this inconsistency by conducting a
sensitivity analysis, which showed no change in the estimates of
the summary sensitivity and the confidence intervals (Allen 2013).
In another sensitivity analysis, we imputed missing data as false-
negative results (that is diagnostic laparoscopy incorrectly classi-
fied unresectable disease as resectable in all the missing partici-
pants) (Allen 2013). We have not presented the results of the first
sensitivity analysis in this update since only participant was mis-
classified, and the impact on results was negligible. We did not
perform the second sensitivity analysis since the reasons for not
performing diagnostic laparoscopy were not reported, and it is
unlikely that all the participants in diagnostic laparoscopy would
have false-negative results.
15Diagnostic accuracy of laparoscopy following computed tomography (CT) scanning for assessing the resectability with curative intent in
pancreatic and periampullary cancer (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Summary of findings
Population Males and females aged 15 to 87 years with potent ially resectable pancreat ic or
periampullary carcinoma on computed tomography (CT) scanning
Setting Surgical centres in the USA, Germany, the UK, Japan, Israel, and the Netherlands
Index test Diagnost ic laparoscopy with histologic conf irmation
Reference standard Paraf f in sect ion histology on diagnost ic laparoscopy or laparotomy or surgeon’s
judgement of unresectability on laparotomy
True posit ive: Suspicious lesion on diagnost ic laparoscopy conf irmed to be
cancer by a histopathological examinat ion of biopsy obtained during diagnost ic
laparoscopy
False posit ive: This is not possible since laparotomy will only be performed if
histopathology of the biopsy of the suspicious lesion on diagnost ic laparoscopy
shows no evidence of cancer
False negat ive: No evidence of unresectability by diagnost ic laparoscopy but
evidence of unresectability on laparotomy
True negat ive: No evidence of unresectability by diagnost ic laparoscopy and
laparotomy
Number of studies 16 studies
Summary sensitivity 64.4% (95% conf idence interval 50.1% to 76.6%)
Consistent results No
Uncertainty (overall risk of bias) High
Other limitations Dif ferent def init ions of unresectability because studies used surgeon’s judgement
of unresectability on laparotomy when biopsy conf irmation was not possible
Pre- test probability from included stud-
ies1
Post- test probability of unresectable
disease for patients with a negative test
result (95% confidence interval)2
Percentage of patients for whom un-
necessary laparotomy can be avoided3
Minimum = 17.4 7.0 (4.9 to 9.8) 10.4
Lower quart ile = 34.7 15.9 (11.4 to 21.6) 18.8
Median = 41.4 20.1 (14.7 to 26.8) 21.3
Upper quart ile = 62.7 37.4 (29.0 to 46.6) 25.3
Maximum = 81.8 61.5 (52.3 to 70.0) 20.3
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Interpretation At pre-test probabilit ies of 17%, 41%, and 82%, adding diagnost ic laparoscopy
to CT scan for the preoperat ive staging of pancreat ic cancer avoids 10, 21, and
20 unnecessary laparotomies out of 100 laparotomies performed for curat ive
resect ion purposes. These pre-test probabilit ies are the minimum, middle, and
maximum values obtained f rom the included studies
1Probability of someone having unresectable disease at laparotomy af ter CT indicated that the disease is resectable.
2Probability of someone having unresectable disease af ter the CT and diagnost ic laparoscopy indicated that the disease is
resectable.
3Calculated as the dif ference between the post-test probability and the pre-test probability.
All probabilit ies are reported in the table as percentages.
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
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D I S C U S S I O N
Summary of main results
We have summarised the results in Summary of findings. The
addition of diagnostic laparoscopy to CT scanning decreases the
probability of unresectable disease from 41% to 20%. This means
that for every 100 patients who receive a CT scan followed by
diagnostic laparoscopy, 21 patients (41 minus 20) will avoid ma-
jor laparotomy compared to with CT scanning alone. Although
this review included studies which were more than 10 years old,
with improvements in CT scanning possible over this period, the
probability of unresectability was high (63.2%) even after multi-
detector row CT using a pancreatic protocol (Table 2). Diagnostic
laparoscopy can either be performed as a separate procedure or im-
mediately prior to major laparotomy as part of a larger procedure.
These two different approaches have distinct advantages and dis-
advantages. The advantages of performing diagnostic laparoscopy
as part of a larger procedure are that the patient needs only one
hospital admission and one general anaesthetic. However, if the
patient is diagnosed as having unresectable disease at laparoscopy
and the subsequent laparotomy is then cancelled, it means that
operation theatre time is wasted. It is also not possible to use paraf-
fin section, the gold standard test, to confirm a histological diag-
nosis of cancer if diagnostic laparoscopy is undertaken as part of
a larger procedure. If laparoscopy is performed as a separate di-
agnostic procedure, the patient must undergo the burden of two
separate hospital admissions and anaesthetics, but no operation
theatre time will be wasted if they are found to have unresectable
disease. The time delay between the two separate procedures also
allows the use of paraffin sections.
We found no complications related to diagnostic laparoscopy in
this systematic review, however the literature reports an injury rate
of 0.23% involving major blood vessels or the bowel (Azevedo
2009). This indicates that diagnostic laparoscopy should only be
performed by appropriately trained healthcare professionals with
expertise in the conduct of diagnostic laparoscopy and biopsy dur-
ing diagnostic laparoscopy.
Strengths and weaknesses of the review
A strength of this review is thatwe placedno restrictions on the lan-
guage of publication and conducted a comprehensive search. We
avoided the use of search filters and undertook additional searches
to find related articles. We also performed a citation search. We
therefore minimised the risk of missing relevant studies. Little is
known about the mechanisms of publication bias for diagnostic
accuracy studies, and so it is not possible to estimate the impact
of unpublished studies on our findings. Nevertheless, the studies
included in this systematic review are likely to be the majority of
studies that provide evidence on this topic. Another strength of
this review is that we used a recommended approach for meta-
analysis.
Our review has some weaknesses. Firstly, our findings are based
on studies with low methodological quality, and there was con-
siderable between-study heterogeneity. There were between-study
differences in the conduct and interpretation of diagnostic la-
paroscopy (in terms of what constitutes a suspicious lesion) and
differences in the assessment of resectability on laparotomy. De-
spite the observed differences in the conduct and interpretation
of diagnostic laparoscopy, the procedure appeared to decrease the
number of unnecessary laparotomies in 15 of the 16 included
studies. With regards to methodological quality, the presence of
selection bias may raise doubts about the applicability of our find-
ings in clinical practice. Secondly, determination of unresectabil-
ity on laparotomy relies on the judgement of individual surgeons,
which may not have been appropriate in some of the studies.
This could have caused an error in the estimation of diagnostic
accuracy. Thirdly, an inappropriate delay between diagnostic la-
paroscopy and laparotomy can result in patients who had previ-
ously resectable cancer developing unresectable cancer because of
local or distant spread. This will underestimate the accuracy of di-
agnostic laparoscopy. Fourthly, inappropriate exclusion of patients
is likely to result in an error in the estimation of diagnostic accu-
racy if the excluded patients had low likelihood of unresectability
or high likelihood of unresectability. We performed a sensitivity
analysis imputing the results according to the worst-case scenario,
that is as false negatives. As mentioned earlier, indeterminate re-
sults at diagnostic laparoscopy will result in the patients undergo-
ing laparotomy.
We were able to identify one previous systematic review on this
topic (Chang 2009). Despite the inclusion of studies in which
histopathological confirmation of suspicious lesions was not ob-
tained, and the lack of meta-analysis on the diagnostic accuracy of
diagnostic laparoscopy, the authors of the review suggested that di-
agnostic laparoscopy decreases unnecessary laparotomy by 4% to
36% and that diagnostic laparoscopy has a role in staging pancre-
atic cancer (Chang 2009). We agree broadly with the conclusions
of the authors of the identified systematic review (Chang 2009).
Applicability of findings to the review question
This review is only applicable to people with pancreatic and peri-
ampullary cancer who have had aCT scan which demonstrated re-
sectable disease prior to diagnostic laparoscopy. This review is also
applicable only when the interval between diagnostic laparoscopy
and laparotomy is sufficient to obtain histopathology results but
not too long for the cancer to spread. Diagnostic laparoscopy ap-
pears to be beneficial in avoiding unnecessary laparotomies, and
the morbidity associated with diagnostic laparoscopy is low. Cost-
effectiveness needs to be formally assessed to inform clinical and
policy decision making in state-funded health care.
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A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Although the methodological quality of the evidence was limited,
diagnostic laparoscopy appears to be useful in decreasing the pro-
portion of people with pancreatic and periampullary cancer that
were found to have resectable disease on CT scanning who will
undergo unnecessary laparotomy.
Implications for research
1. Well-designed diagnostic test accuracy studies are needed to
reliably estimate the accuracy of diagnostic laparoscopy.
Comparison with positron emission tomography (PET)
scanning, endoscopic ultrasound (EUS), and laparoscopic
ultrasound may further demonstrate the value of diagnostic
laparoscopy in staging pancreatic and periampullary cancers.
2. The conclusion of this study needs regular review as the
quality of CT scanning improves, and diagnostic laparoscopy
should be compared with other tests for staging pancreatic and
periampullary cancers.
3. Cost-effectiveness studies should be undertaken to
determine whether diagnostic laparoscopy should be routinely
performed in state-funded clinical practice.
A C K N OW L E D G E M E N T S
We thank the Cochrane Upper Gastrointestinal and Pancreatic
Diseases Group, the UK Support Unit for Diagnostic Test Accu-
racy (DTA) Reviews, and the DTA editorial team for their advice
in the preparation of this review.
R E F E R E N C E S
References to studies included in this review
Ahmed 2006 {published data only}
Ahmed SI, Bochkarev V, Oleynikov D, Sasson AR. Patients
with pancreatic adenocarcinoma benefit from staging
laparoscopy. Journal of Laparoendoscopic & Advanced
Surgical Techniques 2006;16(5):458–63.
Arnold 1999 {published data only}
Arnold JC, Neubauer HJ, Zopf T, Schneider A, Benz C,
Adamek HE, et al. Improved tumor staging by diagnostic
laparoscopy. Zeitschrift Fur Gastroenterologie 1999;37(6):
483–8.
Arnold 2001a {published data only}
Arnold JC, Schneider AR, Zopf T, Neubauer HJ, Jakobs R,
Benz C, et al. Laparoscopic tumor staging in gastrointestinal
carcinomas: significance of internal medicine laparoscopy
[Laparoskopisches tumorstaging bei gastrointestinalen
karzinomen: bedeutung der internistischen laparoskopie].
Zeitschrift Fur Gastroenterologie 2001;39 Suppl 1:19–23.
Beenen 2014 {published data only}
Beenen E, van Roest MHG, Sieders E, Peeters P, Porte RJ,
de Boer MT, et al. Staging laparoscopy in patients scheduled
for pancreaticoduodenectomy minimizes hospitalization in
the remaining life time when metastatic carcinoma is found.
European Journal of Surgical Oncology 2014;40(8):989–94.
Brooks 2002 {published data only}
Brooks AD,Mallis MJ, Brennan MF, Conlon KC. The value
of laparoscopy in the management of ampullary, duodenal,
and distal bile duct tumors. Journal of Gastrointestinal
Surgery 2002; Vol. 6, issue 2:139–45.
Contreras 2009 {published data only}
Contreras CM, Stanelle EJ, Mansour J, Hinshaw JL, Rikkers
LF, Rettammel R, et al. Staging laparoscopy enhances the
detection of occult metastases in patients with pancreatic
adenocarcinoma. Journal of Surgical Oncology 2009;100(8):
663–9.
Fernandez-Castillo 1995 {published data only}
Fernandez-Castillo C, Rattner DW, Warshaw AL. Further
experience with laparoscopy and peritoneal cytology in the
staging of pancreatic cancer. British Journal of Surgery 1995;
82(8):1127–9.
John 1995 {published data only}
John TG, Greig JD, Carter DC, Garden OJ. Carcinoma
of the pancreatic head and periampullary region. Tumor
staging with laparoscopy and laparoscopic ultrasonography.
Annals of Surgery 1995; Vol. 221, issue 2:156–64.
Kishiwada 2002 {published data only}
Kishiwada M, Kawarada Y, Taoka H, Isaji S. Management
of advanced pancreatic cancer: Staging laparoscopy
and immunochemotherapy - a new treatment strategy.
Hepatogastroenterology 2002;49(48):1704–6.
Lavy 2012 {published data only}
Lavy R, Gatot I, Markon I, Shapira Z, Chikman B, Copel
L, et al. The role of diagnostic laparoscopy in detecting
minimal peritoneal metastatic deposits in patients with
pancreatic cancer scheduled for curative resection. Surgical
Laparoscopy, Endoscopy and Percutaneous Techniques 2012;22
(4):358–60.
Menack 2001 {published data only}
Menack MJ, Spitz JD, Arregui ME. Staging of pancreatic
and ampullary cancers for resectability using laparoscopy
with laparoscopic ultrasound. Surgical Endoscopy 2001;15
(10):1129–34.
Merchant 1998 {published data only}
Conlon KC, Dougherty E, Klimstra DS, Coit DG,
Turnbull AD, Brennan MF. The value of minimal access
surgery in the staging of patients with potentially resectable
19Diagnostic accuracy of laparoscopy following computed tomography (CT) scanning for assessing the resectability with curative intent in
pancreatic and periampullary cancer (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
peripancreatic malignancy. Annals of Surgery 1996;223(2):
134–40.
Merchant NB, Conlon KC. Laparoscopic evaluation in
pancreatic cancer. Seminars in Surgical Oncology 1998;15
(3):155–65.
Minnard EA, Conlon KC, Hoos A, Dougherty EC, Hann
LE, Brennan MF. Laparoscopic ultrasound enhances
standard laparoscopy in the staging of pancreatic cancer.
Annals of Surgery 1998;228(2):182–7.
Reddy 1999 {published data only}
Reddy KR, Levi J, Livingstone A, Jeffers L, Molina E,
Kligerman S, et al. Experience with staging laparoscopy in
pancreatic malignancy. Gastrointestinal Endoscopy 1999;49
(4 Part 1):498–503.
Reed 1997 {published data only}
Reed WP, Mustafa IA. Laparoscopic screening of surgical
candidates with pancreatic cancer or liver tumors. Surgical
Endoscopy 1997;11(1):12–4.
Shah 2008 {published data only}
Shah D, Fisher WE, Hodges SE, Wu MF, Hilsenbeck SG,
Charles Brunicardi F. Preoperative prediction of complete
resection in pancreatic cancer. The Journal of Surgical
Research 2008;147(2):216–20.
Warshaw 1986 {published data only}
Warshaw AL, Tepper JE, Shipley WU. Laparoscopy in
the staging and planning of therapy for pancreatic cancer.
American Journal of Surgery 1986;151(1):76–80.
References to studies excluded from this review
Abdalla 2003 {published data only}
Abdalla EK, Barnett CC, Pisters PW, Cleary KR, Evans
DB, Feig BW, et al. Subaquatic laparoscopy for staging of
intraabdominal malignancy. Journal of the American College
of Surgeons 2003;196(1):155–8.
Adisa 2014 {published data only}
Adisa AO, Lawal OO, Adesunkanmi AR, Adejuyigbe
O. Impact of introduction of laparoscopic surgery on
management of unresolved intra-abdominal malignancies
in a West African hospital. World Journal of Surgery 2014;
38(10):2519–24.
Alexakis 2015 {published data only}
Alexakis N, Gomatos IP, Sbarounis S, Toutouzas K,
Katsaragakis S, Zografos G, et al. High serum Ca 19-9 but
not tumor size should select patients for staging laparoscopy
in radiological resectable pancreas head and peri-ampullary
cancer. European Journal of Surgical Oncology 2015;41(2):
265–9.
Altieri 1982 {published data only}
Altieri A, Roggia G, Ciavarella G, Tricarico F. The
contribution of laparoscopy to the diagnosis of abdominal
masses. Personal experience. [Italian]. Minerva Chirurgica
1982;37(5):427–9.
Andren-Sandberg 1998 {published data only}
Andren-Sandberg A, Lindberg CG, Lundstedt C, Ihse I.
Computed tomography and laparoscopy in the assessment
of the patient with pancreatic cancer. Journal of the American
College of Surgeons 1998;186(1):35–40.
Arnold 2001 {published data only}
Arnold JC, Schneider ARJ, Zopf T, Riemann JF.
Laparoscopic tumor staging - a safe method in the hands of
internists. Klinikarzt 2001;30(5):142–6.
Atanov 1972 {published data only}
Atanov YP, Gallinger YI. Laparoscopy in the diagnosis of
some abdominal tumors. Sovetskaya Meditsina 1972;35(5):
93–8.
Awad 1997 {published data only}
Awad SS, Colletti L, Mulholland M, Knol J, Rothman
ED, Scheiman J, et al. Multimodality staging optimizes
resectability in patients with pancreatic and ampullary
cancer. American Surgeon 1997;63(7):634–8.
Baghbanian 2013 {published data only}
Baghbanian M, Salmanroghani H, Baghbanian A,
Bakhtpour M, Shabazkhani B. Efficacy of multi-detector
computerized tomography scan, endoscopic ultrasound, and
laparoscopy for predicting tumor resectability in pancreatic
adenocarcinoma. Indian Journal of Gastroenterology 2013;
32(6):376–80.
Baghbanian 2014 {published data only}
Baghbanian M, Salmanroghani H, Baghbanian A,
Bakhtpour M, Shabazkhani B. Resectability of the
pancreatic adenocarcinoma: A study from Iran. Advanced
Biomedical Research 2014;3:265.
Balcom 2000 {published data only}
Balcom JH, Fernandez-del Castillo C. Can we predict
resectability in pancreatic cancer?. Annals of Gastroenterology
2000;13(3):201–6.
Barabino 2011 {published data only}
Barabino M, Santambrogio R, Pisani Ceretti A, Scalzone R,
Montorsi M, Opocher E. Is there still a role for laparoscopy
combined with laparoscopic ultrasonography in the staging
of pancreatic cancer?. Surgical Endoscopy 2011;25(1):160–5.
Barrat 1998 {published data only}
Barrat C, Champault G, Catheline JM. Is laparoscopic
evaluation of digestive cancers legitimate? A prospective
study of 109 cases. Annales De Chirurgie 1998;52(7):602–6.
Barreiro 2002 {published data only}
Barreiro CJ, Lillemoe KD, Koniaris LG, Sohn TA, Yeo CJ,
Coleman J, et al. Diagnostic laparoscopy for periampullary
and pancreatic cancer: What is the true benefit?. Journal of
Gastrointestinal Surgery 2002;6(1):75–81.
Barthet 2007 {published data only}
Barthet M, Moutardier V, Marciano S. Pancreatic
adenocarcinoma: Which assessment to appreciate the
resection?. Gastroenterologie Clinique Et Biologique 2007;31
(2):216–21.
Baumgarten 1984 {published data only}
Baumgarten R, Fengler JD. Current diagnostic value of
laparoscopy. Zeitschrift für ärztliche Fortbildung 1984;78
(20):841–2.
20Diagnostic accuracy of laparoscopy following computed tomography (CT) scanning for assessing the resectability with curative intent in
pancreatic and periampullary cancer (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Beger 1997 {published data only}
Beger HG, Schoenberg MH. The role of laparoscopy and
ultrasonography in pancreatic head carcinoma. HPB Surgery
1997;10(3):186–8.
Belagyi 2000 {published data only}
Belagyi T, Olah A. Pancreatic head mass: what can be done?
Diagnosis: laparoscopy. Journal of the Pancreas 2000;1(3
Suppl):123–6.
Bemelman 1995 {published data only}
Bemelman WA, de Wit LT, van Delden OM, Smits NJ,
Obertop H, Rauws EJ, et al. Diagnostic laparoscopy
combined with laparoscopic ultrasonography in staging of
cancer of the pancreatic head region. British Journal of
Surgery 1995;82(6):820–4.
Bohmig 2001 {published data only}
Bohmig M, Wiedenmann B, Rosewicz S. Diagnosis and
staging of carcinoma of the pancreas. [German]. Deutsche
Medizinische Wochenschrift 2001;126(5):113–6.
Borbath 2005 {published data only}
Borbath I, Van Beers BE, Lonneux M, Schoonbroodt
D, Geubel A, Gigot JF, et al. Preoperative assessment of
pancreatic tumors using magnetic resonance imaging,
endoscopic ultrasonography, positron emission tomography
and laparoscopy. Pancreatology 2005;5(6):553–61.
Boselli 2000 {published data only}
Boselli C, Trebuchet G, Bufalari A, De Santis F, Cirocchi
R, Giustozzi G. Laparoscopic staging in surgical oncology.
EAES: Proceedings of the 8th International Congress of
the European Association for Endoscopic Surgery. 2000:
647–52.
Bottger 1998 {published data only}
Bottger TC, Boddin J, Duber C, Heintz A, Kuchle
R, Junginger T. Diagnosing and staging of pancreatic
carcinoma - what is necessary?. Oncology 1998;55(2):
122–9.
Boyce 1992 {published data only}
Boyce HW, Henning H. Diagnostic laparoscopy 1992:
Time for a new look. Endoscopy 1992;24(8):671–3.
Caldironi 1996 {published data only}
Caldironi MW, Zani S, Mazzucco M, Paccagnella D,
Aldinio MT, Costantin G, et al. Ultrasound-guided fine
needle biopsy and laparoscopy in the study of pancreatic
masses: report on 136 cases. General & Diagnostic Pathology
1996;141(5-6):313–8.
Callery 1997 {published data only}
Callery MP, Strasberg SM, Doherty GM, Soper NJ, Norton
JA. Staging laparoscopy with laparoscopic ultrasonography:
optimizing resectability in hepatobiliary and pancreatic
malignancy. Journal of the American College of Surgeons
1997;185(1):33–9.
Callery 2009 {published data only}
Callery MP, Chang KJ, Fishman EK, Talamonti MS,
William Traverso L, Linehan DC. Pretreatment assessment
of resectable and borderline resectable pancreatic cancer:
Expert consensus statement. Annals of Surgical Oncology
2009;16(7):1727–33.
Camacho 2005 {published data only}
Camacho D, Reichenbach D, Duerr GD, Venema TL,
Sweeney JF, Fisher WE. Value of laparoscopy in the staging
of pancreatic cancer. Journal of the Pancreas 2005;6(6):
552–61.
Carmichael 1995 {published data only}
Carmichael AR, Jackson BT. Diagnostic laparoscopy
combined with laparoscopic ultrasonography in staging of
cancer of the pancreatic head region. British Journal of
Surgery 1995;82(12):1703–4.
Carpenter 1996 {published data only}
Carpenter SL, Scheiman JM. Pancreatic imaging. Current
Opinion in Gastroenterology 1996;12(5):442–7.
Catheline 1998 {published data only}
Catheline JM, Polliand C, Risk N, Barrat C, Champault G.
Staging of pancreatic cancer by laparoscopy and laparoscopic
ultrasonography. Chirurgie 1998;123(3):271–9.
Catheline 1999 {published data only}
Catheline JM, Turner R, Rizk N, Barrat C, Champault G.
The use of diagnostic laparoscopy supported by laparoscopic
ultrasonography in the assessment of pancreatic cancer.
Surgical Endoscopy 1999;13(3):239–45.
Chambon 1995 {published data only}
Chambon JP, Bosse JL, Denimal F, Porte H, Quandalle
P. Place of celioscopy in the diagnosis of invasiveness of
digestive cancers. Annales de Chirurgie 1995;49(6):513–8.
Champault 1996 {published data only}
Champault G, Catheline JM, Rizk N, Boutelier P. The
use of laparoscopic ultrasound in the staging of pancreatic
cancers. Annales de Chirurgie 1996;50(10):875–85.
Champault 1997 {published data only}
Champault G. The use of laparoscopic ultrasound in the
assessment of pancreatic cancer. Wiad Lek 1997;50 Suppl
Pt 1:195–203.
Charukhchyan 1998 {published data only}
Charukhchyan SA, Lucas GW. Lesser sac endoscopy and
laparoscopy in pancreatic carcinoma definitive diagnosis,
staging and palliation. American Journal of Surgery 1998;64
(9):809–14.
Cipollone 2012 {published data only}
Cipollone I, Kelly M, Corbally C, Torreggiani W,
Ridgway PF, Conlon KC. Is there still a utility for selected
laparoscopic staging in pancreas cancer with contemporary
multi detector CT scanning?. Pancreatology 2012;12(3):
e12.
Conlon 1997 {published data only}
Conlon KCP, Minnard EA. The value of laparoscopic
staging in upper gastrointestinal malignancy. Oncologist
1997;2(1):10–7.
Conlon 1999 {published data only}
Conlon KC. Value of laparoscopic staging for upper
gastrointestinal malignancies. Journal of Surgical Oncology
1999;71(2):71–3.
21Diagnostic accuracy of laparoscopy following computed tomography (CT) scanning for assessing the resectability with curative intent in
pancreatic and periampullary cancer (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Conlon 2002 {published data only}
Conlon KC, McMahon RL. Minimally invasive surgery in
the diagnosis and treatment of upper gastrointestinal tract
malignancy. Annals of Surgical Oncology 2002;9(8):725–37.
Connor 2004 {published data only}
Connor S, Neoptolemos JP. Laparoscopy is still necessary in
the assessment of peri-ampullary neoplasia. Pancreatology
2004;4(5):415–6.
Croome 2009 {published data only}
Croome K, Jayaraman S, Schlachta C. Preoperative
staging in cancer of the pancreatic head: is there room for
improvement?. Asia-Pacific Journal of Clinical Oncology
2009;5:A192.
Croome 2010 {published data only}
Croome KP, Jayaraman S, Schlachta CM. Preoperative
staging of cancer of the pancreatic head: Is there room for
improvement?. Canadian Journal of Surgery 2010;53(3):
171–4.
Cuesta 1993 {published data only}
Cuesta MA, Meijer S, Borgstein PJ, Sibinga Mulder
L, Sikkenk AC. Laparoscopic ultrasonography for
hepatobiliary and pancreatic malignancy. British Journal of
Surgery 1993;80(12):1571–4.
Cuschieri 1978 {published data only}
Cuschieri A, Hall AW, Clark J. Value of laparoscopy in the
diagnosis and management of pancreatic carcinoma. Gut
1978;19(7):672–7.
Cuschieri 1988 {published data only}
Cuschieri A. Laparoscopy for pancreatic cancer: does it
benefit the patient?. European Journal of Surgical Oncology
1988;14(1):41–4.
D’Angelica 2003 {published data only}
D’Angelica M, Fong Y, Weber S, Gonen M, DeMatteo
RP, Conlon K, et al. The role of staging laparoscopy in
hepatobiliary malignancy: Prospective analysis of 401 cases.
Annals of Surgical Oncology 2003;10(2):183–9.
Dadan 1980 {published data only}
Dadan H, Boron P, Szpakowicz T, Nowak H, Kurasz
S, Zalewski J, et al. Diagnostic value of preoperative
laparoscopy in detection of neoplastic changes. Polski
Przeglad Chirurgiczny 1980;52(4):307–10.
Doran 2004 {published data only}
Doran HE, Bosonnet L, Connor S, Jones L, Garvey C,
Hughes M, et al. Laparoscopy and laparoscopic ultrasound
in the evaluation of pancreatic and periampullary tumours.
Digestive Surgery 2004;21(4):305–13.
Doucas 2007 {published data only}
Doucas H, Sutton CD, Zimmerman A, Dennison AR, Berry
DP. Assessment of pancreatic malignancy with laparoscopy
and intraoperative ultrasound. Surgical Endoscopy 2007;21
(7):1147–52.
Duffy 2008 {published data only}
Duffy A, O’Reilly EM. What is the optimal treatment of
localized pancreatic adenocarcinoma?. Oncology-New York
2008;22(11):1283–91.
Durup Scheel-Hincke 1999 {published data only}
Durup Scheel-Hincke J, Mortensen MB, Qvist N,
Hovendal CP. TNM staging and assessment of resectability
of pancreatic cancer by laparoscopic ultrasonography.
Surgical Endoscopy 1999;13(10):967–71.
Eigler 1999 {published data only}
Eigler FW, Hossfeld DK, Junginger T, Kloppel G, Kruck
P, Meyer HJ, et al. Guidelines for exocrine pancreas
carcinoma. Onkologe 1999;5(3):257–60.
Ellsmere 2005 {published data only}
Ellsmere J, Mortele K, Sahani D, Maher M, Cantisani V,
Wells W, et al. Does multidetector-row CT eliminate the
role of diagnostic laparoscopy in assessing the resectability
of pancreatic head adenocarcinoma?. Surgical Endoscopy
2005;19(3):369–73.
Enestvedt 2008 {published data only}
Enestvedt CK, Mayo SC, Diggs BS, Mori M, Austin DA,
Shipley DK, et al. Diagnostic laparoscopy for patients with
potentially resectable pancreatic adenocarcinoma: Is it cost-
effective in the current era?. Journal of Gastrointestinal
Surgery 2008;12(7):1177–84.
Mayo SC, Austin DF, Sheppard BC, Mori M, Shipley DK,
Billingsley KG. Evolving preoperative evaluation of patients
with pancreatic cancer: Does laparoscopy have a role in
the current era?. Journal of the American College of Surgeons
2009;208(1):87–95.
Fernandez-del Castillo 1994 {published data only}
Fernandez-del Castillo C, Warshaw AL. Preoperative
evaluation of adenocarcinoma of the pancreas:
Massachusetts General Hospital experience. Cancer Bulletin
1994;46(6):492–8.
Fernandez-del Castillo 1998 {published data only}
Fernandez-del Castillo C, Warshaw AL. Laparoscopic
staging and peritoneal cytology. Surgical Oncology Clinics of
North America 1998;7(1):135–42.
Ferrone 2006 {published data only}
Ferrone CR, Haas B, Tang L, Coit DG, Fong Y, Brennan
MF, et al. The influence of positive peritoneal cytology
on survival in patients with pancreatic adenocarcinoma.
Journal of Gastrointestinal Surgery 2006;10(10):1347–53.
Feussner 2000 {published data only}
Feussner H, Baumgartner M, Siewert JR. Extended
diagnostic laparoscopy (EDL). Acta Chirurgica Austriaca
2000;32(5):212–20.
Fevery 1985 {published data only}
Fevery J, Baert AL, Marchal GM, Broeckaert L, De Groote
J, Vantrappen G. The value of computed tomography,
ultrasonography, and peritoneoscopy with biopsy in
the detection of liver metastases secondary to gastro-
enterological tumors. Acta Gastro-Enterologica Belgica 1985;
48(2):105–10.
Fockens 1993 {published data only}
Fockens P, Huibregtse K. Staging of pancreatic and
ampullary cancer by endoscopy. Endoscopy 1993;25(1):
52–7.
22Diagnostic accuracy of laparoscopy following computed tomography (CT) scanning for assessing the resectability with curative intent in
pancreatic and periampullary cancer (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Friess 1997 {published data only}
Friess H, Baer HU, Sadowski C, Buchler MW. Efficacy and
economic aspects of preoperative diagnosis: laparoscopy is
useful in only 13% of patients with pancreatic carcinoma.
Langenbecks Archiv für Chirurgie. Supplement. Kongressband
1997;114:474–6.
Friess 1998 {published data only}
Friess H, Kleeff J, Silva JC, Sadowski C, Baer HU, Buchler
MW. The role of diagnostic laparoscopy in pancreatic and
periampullary malignancies. Journal of the American College
of Surgeons 1998;186(6):675–82.
Fristrup 2006 {published data only}
Fristrup CW, Mortensen MB, Pless T, Durup J, Ainsworth
A, Hovendal C, et al. Combined endoscopic and
laparoscopic ultrasound as preoperative assessment of
patients with pancreatic cancer. HPB 2006;8(1):57–60.
Fukumoto 1989 {published data only}
Fukumoto Y, Okita K, Takemoto T. Utility of laparoscopic
ultrasonography in the diagnosis of hepato-biliary and
pancreatic carcinoma. Zeitschrift Fur Gastroenterologie 1989;
27(Special Issue):92–7.
Garcea 2012 {published data only}
Garcea G, Cairns V, Berry DP, Neal CP, Metcalfe MS,
Dennison AR. Improving the diagnostic yield from staging
laparoscopy for periampullary malignancies: the value of
preoperative inflammatory markers and radiological tumor
size. Pancreas 2012;41(2):233–7.
Garofalo 2009 {published data only}
Garofalo A, Valle M. Laparoscopy in the management of
peritoneal carcinomatosis. The Cancer Journal 2009;15(3):
190–5.
Gouma 1996 {published data only}
Gouma DJ, de Wit LT, Nieveen van Dijkum E, Van
Delden O, Bemelman WA, Rauws EA, et al. Laparoscopic
ultrasonography for staging of gastrointestinal malignancy.
Scandinavian Journal of Gastroenterology 1996;31 Suppl
218:43–9.
Gouma 1999 {published data only}
Gouma DJ, van Dijkum E, Obertop H. The standard
diagnostic work-up and surgical treatment of pancreatic
head tumours. European Journal of Surgical Oncology 1999;
25(2):113–23.
Gouma 2002 {published data only}
Gouma DJ, Obertop H. Management of hepatobiliary
and pancreatic disorders at the Academic Medical Center
Amsterdam, Netherlands. HPB 2002;4(1):35–7.
Hann 1997 {published data only}
Hann LE, Conlon KC, Dougherty EC, Hilton S, Bach AM,
Brennan MF. Laparoscopic sonography of peripancreatic
tumors: Preliminary experience. American Journal of
Roentgenology 1997;169(5):1257–62.
Hashimoto 2015 {published data only}
Hashimoto D, Chikamoto A, Sakata K, Nakagawa S,
Hayashi H, Ohmuraya M, et al. Staging laparoscopy
leads to rapid induction of chemotherapy for unresectable
pancreatobiliary cancers. Asian Journal of Endoscopic Surgery
2015;8(1):59–62.
Healthcare 1999 {published data only}
Healthcare IBvoorz. Laparoscopy in pancreas cancer - primary
research (brief record). Diemen: Healthcare Insurance
Board/College voor Zorgverzekeringen (CVZ), 1999.
Heger 2008 {published data only}
Heger U, Buchler MW, Weitz J. Diagnostics of pancreatic
carcinoma. Tumor Diagnostik und Therapie 2008;29(5):
246–9.
Hernandezguio 1965 {published data only}
Hernandezguio C. Our experiences with laparoscopic
exploration. Revista Española de las Enfermedades del Aparato
Digestivo y de la Nutrición 1965;24:216–23.
Herrera 2003 {published data only}
Herrera MF, Velazquez D, Bezauri P, Angeles-Angeles
A, Uscanga LF, Robles-Diaz G. Role of laparoscopy
with ultrasound in the staging process of pancreatic and
ampullary tumors. Gaceta Médica de México 2003;139(1):
21–5.
Hidalgo 2004 {published data only}
Hidalgo Pascual M, Ferrero Herrero E, Castillo Fe MJ,
Guadarrama Gonzalez FJ, Pelaez Torres P, Botella Ballesteros
F. Epidemiology and diagnosis of the pancreatic cancer.
Revista Espanola de Enfermedades Digestivas 2004;96(10):
714–22.
Hohenberger 2000 {published data only}
Hohenberger P, Hunerbein M, Rau B, Schlag PM.
Staging laparoscopy - indication, surgical technique and
significance in the therapeutical concept of malignant
tumors. Viszeralchirurgie 2000;35(1):2–7.
Holzman 1997 {published data only}
Holzman MD, Reintgen KL, Tyler DS, Pappas TN.
The role of laparoscopy in the management of suspected
pancreatic and periampullary malignancies. Journal of
Gastrointestinal Surgery 1997;1(3):236–43.
Hunerbein 1999 {published data only}
Hunerbein M, Rau B, Schlag PM. Role of staging
laparoscopy. Minimally invasive and endoscopic therapy in
pancreas carcinoma. Onkologe 1999;5(3):203–7.
Hunerbein 2001 {published data only}
Hunerbein M, Rau B, Hohenberger P, Schlag PM. Value
of laparoscopic ultrasound for staging of gastrointestinal
tumors. Der Chirurg; Zeitschrift für alle Gebiete der
operativen Medizen 2001;72(8):914–9.
Ialongo 2010 {published data only}
Ialongo P, Ferrarese F, Pannarale O, Panebianco A, Volpi
A, Palasciano N. The role of laparoscopy in surgical
treatment of pancreatic cancer [Il ruolo della laparoscopia
nel trattamento chirurgico del carcinoma pancreatico].
Annali Italiani di Chirurgia 2010;81(4):295–9.
Ialongo 2015 {published data only}
Ialongo P, Milella M, Pascazio B, Prestera A, Pannarale
O, Panebianco A, et al. Laparoscopic management of
23Diagnostic accuracy of laparoscopy following computed tomography (CT) scanning for assessing the resectability with curative intent in
pancreatic and periampullary cancer (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
pancreatic cancer. Our experience. Annali Italiani di
Chirurgia 2015;86:518–23.
Ido 1982 {published data only}
Ido K. Laparoscopic observation of pancreatic cancer.
Gastroenterological Endoscopy 1982;24(7):1164–5.
Ihse 1984 {published data only}
Ihse I, Isaksson G. Preoperative and operative diagnosis
of pancreatic cancer. World Journal of Surgery 1984;8(6):
846–53.
Ishida 1983 {published data only}
Ishida H. Peritoneoscopy and pancreas biopsy in the
diagnosis of pancreatic diseases. Gastrointestinal Endoscopy
1983;29(3):211–8.
Ishida 1984 {published data only}
Ishida H, Dohzono T, Furukawa Y. Laparoscopy and biopsy
in the diagnosis of malignant intra-abdominal tumors.
Endoscopy 1984;16(4):140–2.
Ivanov 1989 {published data only}
Ivanov S, Keranov S. Laparoscopic assessment of the
operability of pancreatic cancer. Khirurgiia 1989;42(1):
12–4.
Jackowski 1997 {published data only}
Jackowski M, Juzkow H, Szeliga J, Zalucki M, Nowak M,
Jedrzejczyk W. Laparoscopic staging in neoplastic diseases -
clinical experience. Acta Endoscopica Polona 1997;7(1):3–5.
Jakobs 1999 {published data only}
Jakobs R, Martin WR, Riemann JF. Current diagnostic
possibilities of pancreas carcinoma. Onkologe 1999;5(3):
194–202.
Jarnagin 2000 {published data only}
Jarnagin WR, Bodniewicz J, Dougherty E, Conlon K,
Blumgart LH, Fong Y. A prospective analysis of staging
laparoscopy in patients with primary and secondary
hepatobiliary malignancies. Journal of Gastrointestinal
Surgery 2000;4(1):34–42.
Jayakrishnan 2015 {published data only}
Jayakrishnan TT, Nadeem H, Groeschl RT, George B,
Thomas JP, Ritch PS, et al. Diagnostic laparoscopy should
be performed before definitive resection for pancreatic
cancer: A financial argument. HPB 2015;17(2):131–9.
Jerby 1998 {published data only}
Jerby BL, Milsom JW. Role of laparoscopy in the staging of
gastrointestinal cancer. Oncology 1998;12(9):1353–60.
Jimenez 2000 {published data only}
Jimenez RE, Warshaw AL, Fernandez-del Castillo C.
Laparoscopy and peritoneal cytology in the staging of
pancreatic cancer. Journal of Hepato-Biliary-Pancreatic
Surgery 2000;7(1):15–20.
Jimenez 2000a {published data only}
Jimenez RE, Warshaw AL, Rattner DW, Willett CG,
McGrath D, Fernandez-del Castillo C. Impact of
laparoscopic staging in the treatment of pancreatic cancer.
Archives of Surgery 2000;135(4):409–14.
John 1999 {published data only}
John TG, Wright A, Allan PL, Redhead DN, Paterson-
Brown S, Carter DC, et al. Laparoscopy with laparoscopic
ultrasonography in the TNM staging of pancreatic
carcinoma. World Journal of Surgery 1999;23(9):870–81.
Juzkow 1996 {published data only}
Juzkow H, Jackowski M, Jedrzejczyk W. Laparoscopy as
a diagnostic and therapeutic method in the treatment of
pancreatic carcinoma. Acta Endoscopica Polona 1996;6(1):
31–3.
Kadar 1997 {published data only}
Kadar E, Nagy P, Faludi S, Jakab F. Diagnostic-staging
laparoscopy. Acta Chirurgica Hungarica 1997;36(1-4):
160–1.
Kanazawa 1983 {published data only}
Kanazawa H, Sakamoto F, Makino T. Laparoscopy in upper
GI malignancies. Gastroenterological Endoscopy 1983;25(9):
1353–65.
Kaplan 1979 {published data only}
Kaplan LR. Medicine grand rounds. Laparoscopy in
internal medicine. Minnesota Medicine 1979;62(12):
889–93.
Karachristos 2005 {published data only}
Karachristos A, Scarmeas N, Hoffman JP. CA 19-9 levels
predict results of staging laparoscopy in pancreatic cancer.
Journal of Gastrointestinal Surgery 2005;9(9):1286–92.
Kellokumpu 1996 {published data only}
Kellokumpu I, Victorzon M. The role of laparoscopic
staging in the assessment of metastasis of upper quadrant
abdominal neoplasms. Duodecim 1996; Vol. 112, issue 4:
257–62.
Kelly 2009 {published data only}
Kelly KJ, Wong J, Gladdy R, Moore-Dalal K, Woo Y,
Gonen M, et al. Prognostic impact of RT-PCR-based
detection of peritoneal micrometastases in patients with
pancreatic cancer undergoing curative resection. Annals of
Surgical Oncology 2009;16(12):3333–9.
Khamdanov 1983 {published data only}
Khamdanov K, Sabirov BU, Salokhiddinov BM.
Laparoscopy in diseases of the liver, biliary tract, and
pancreas. Khirurgiia 1983, (8):143–6.
Kiyonaga 1982 {published data only}
Kiyonaga G, Miyamoto S, Kita R, Yukawa E. Laparoscopy
and biopsy. Nippon Rinsho 1982;40(3):660–9.
Klingler 2000 {published data only}
Klingler A, Klocker J, Springer R, Kober F, Glaser K.
Combined laparoscopy and laparoscopic ultrasonography
in the oncologic diagnostics of pancreas and liver. Acta
Chirurgica Austriaca 2000;32(5):228–32.
Krahenbuhl 1997 {published data only}
Krahenbuhl L, Buchler MW. Update in laparoscopic
surgery. Digestive Surgery 1997;14(5):331–2.
24Diagnostic accuracy of laparoscopy following computed tomography (CT) scanning for assessing the resectability with curative intent in
pancreatic and periampullary cancer (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Krustev 1998 {published data only}
Krustev N, Grigorov N. Laparoscopy and laparoscopic
echography in the diagnosis of pancreatic diseases.
Khirurgiia 1998;51(2):20–4.
Kubyshkin 2000 {published data only}
Kubyshkin VA, Vishnevskii VA, Airapetian AT,
Karmazanovskii GG, Kuntsevich GI, Starkov IG.
Differential diagnosis of pancreatic head cancer. Khirurgiia
2000;11:19–23.
Kuster 1967 {published data only}
Kuster G, Biel F. Accuracy of laparoscopic diagnosis. The
American Journal of Medicine 1967;42(3):388–93.
Kwon 2002 {published data only}
Kwon AH, Inui H, Kamiyama Y. Preoperative
laparoscopic examination using surgical manipulation and
ultrasonography for pancreatic lesions. Endoscopy 2002;34
(6):464–8.
Lavonius 2001 {published data only}
Lavonius MI, Laine S, Salo S, Sonninen P, Ovaska J. Role
of laparoscopy and laparoscopic ultrasound in staging of
pancreatic tumours. Annales Chirurgiae et Gynaecologiae
2001;90(4):252–5.
Lightdale 1992 {published data only}
Lightdale CJ. Laparoscopy for cancer staging. Endoscopy
1992;24(8):682–6.
Liu 2004 {published data only}
Liu RC, Traverso LW. Laparoscopic staging should be used
routinely for locally extensive cancer of the pancreatic head.
Journal of Gastrointestinal Surgery 2004;8(8):923–4.
Long 2005 {published data only}
Long EE, Van Dam J, Weinstein S, Jeffrey B, Desser
T, Norton JA. Computed tomography, endoscopic,
laparoscopic, and intra-operative sonography for assessing
resectability of pancreatic cancer. Surgical Oncology 2005;
14(2):105–13.
Luque-de Leon 1998 {published data only}
Luque-de Leon E, Tsiotos GG, Balsiger BM, Barnwell J,
Burgart L, Sarr MG. Staging laparoscopy for pancreatic
cancer should be used to select the best palliation, not
to increase resection rate. Gastroenterology 1998;114(4):
A1407.
Luque-de Leon 1999 {published data only}
Luque-de Leon E, Tsiotos GG, Balsiger B, Barnwell J,
Burgart LJ, Sarr MG. Staging laparoscopy for pancreatic
cancer should be used to select the best means of palliation
and not only to maximize the resectability rate. Journal of
Gastrointestinal Surgery 1999;3(2):111–7.
Macutkiewicz 2009 {published data only}
Macutkiewicz C, Manu M, Sherlock D, O’Reilly D.
Platelet-lymphocyte ratio and serum carbohydrate antigen
19-9 levels aid in patient selection for staging laparoscopy in
suspected pancreatic malignancy. Pancreatology 2009;9(4):
525.
Madsen 1994 {published data only}
Madsen MR, Bau Mortensen M, Hovendal C. Explorative
laparotomy or laparoscopy in patients with carcinoma of the
stomach and pancreas?. Minimally Invasive Therapy 1994;3
(5):267–70.
Madsen 1994a {published data only}
Madsen MR, Mortensen MB, Hovendal CP. Preoperative
laparoscopic evaluation of patients with upper
gastrointestinal cancer. Ugeskrift For Laeger 1994;156(34):
4810–2.
Maire 2004 {published data only}
Maire F, Sauvanet A, Trivin F, Hammel P, O’Toole D,
Palazzo L, et al. Staging of pancreatic head adenocarcinoma
with spiral CT and endoscopic ultrasonography: An indirect
evaluation of the usefulness of laparoscopy. Pancreatology
2004;4(5):436–40.
Maithel 2008 {published data only}
Maithel SK, Maloney S, Winston C, Gonen M, D’Angelica
MI, DeMatteo RP, et al. Preoperative CA 19-9 and the yield
of staging laparoscopy in patients with radiographically
resectable pancreatic adenocarcinoma. Annals of Surgical
Oncology 2008;15(12):3512–20.
Meduri 1994 {published data only}
Maffei Faccioli A, Meduri F, Caldironi MW, Diana F,
Losacco L, Merenda R, et al. The role of laparoscopy and
peritoneal cytology in the preoperative staging of pancreatic
carcinoma. Chirurgia Italiana 1994;46(2):26–9.
Meduri F, Diana F, Merenda R, Caldironi MW, Zuin
A, Losacco L, et al. Implication of laparoscopy and
peritoneal cytology in the staging of early pancreatic cancer.
Zentralblatt für Pathologie 1994; Vol. 140, issue 3:243–6.
Metcalfe 2003 {published data only}
Metcalfe MS, Maddern GJ. Laparoscopic staging of upper
gastrointestinal malignancy. ANZ Journal of Surgery 2003;
73(10):782–3.
Meyer 1973 {published data only}
Meyer Burg J, Ziegler U, Kirstaedter HJ, Palme G.
Peritoneoscopy in carcinoma of the pancreas. Report of 20
cases. Endoscopy 1973;5(2):86–90.
Misra 2012 {published data only}
Misra N, Battersby C, Staettner S, Grimes N, McChesney
E, Poston G, et al. The role of laparoscopy and tumour
biomarkers in potentially resectable hepatobiliary disease;
experience from a regional hepatobiliary centre. HPB 2012;
14:555–6.
Molnar 2010 {published data only}
Molnar G, Iancu C, Munteanu D, Muntean V, Al Hajjarz
N, Bala O, et al. The role of diagnostic laparoscopy in
periampullary and pancreatic cancers. A study based on 27
cases. Chirurgia 2010;105(3):383–6.
Morak 2009 {published data only}
Morak MJ, Hermans JJ, Smeenk HG, Renders WM,
Nuyttens JJ, Kazemier G, et al. Staging for locally advanced
pancreatic cancer. European Journal of Surgical Oncology
2009;35(9):963–8.
Morganti 2005 {published data only}
Morganti AG, Brizi MG, Macchia G, Sallustio G,
Costamagna G, Alfieri S, et al. The prognostic effect of
25Diagnostic accuracy of laparoscopy following computed tomography (CT) scanning for assessing the resectability with curative intent in
pancreatic and periampullary cancer (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
clinical staging in pancreatic adenocarcinoma. Annals of
Surgical Oncology 2005;12(2):145–51.
Mortensen 1996 {published data only}
Mortensen MB, Scheel-Hincke JD, Madsen MR, Qvist
N, Hovendal C. Combined endoscopic ultrasonography
and laparoscopic ultrasonography in the pretherapeutic
assessment of resectability in patients with upper
gastrointestinal malignancies. Scandinavian Journal of
Gastroenterology 1996;31(11):1115–9.
Muniraj 2013 {published data only}
Muniraj T, Barve P. Laparoscopic staging and surgical
treatment of pancreatic cancer. North American Journal of
Medical Sciences 2013;5(1):1–9.
Muntean 2009 {published data only}
Muntean V, Oniu T, Lungoci C, Fabian O, Munteanu D,
Molnar G, et al. Staging laparoscopy in digestive cancers.
Journal of Gastrointestinal and Liver Diseases 2009;18(4):
461–7.
Munteanu 2010 {published data only}
Munteanu D, Iancu C, Munteanu A, Muntean V, Molnar
G, Mocan T, et al. Is staging laparoscopy in radiologically
resectable pancreatic tumours still useful?. European Journal
of Surgical Oncology 2010;36(9):899.
Murugiah 1993 {published data only}
Murugiah M, Paterson-Brown S, Windsor JA, Miles
WF, Garden OJ. Early experience of laparoscopic
ultrasonography in the management of pancreatic
carcinoma. Surgical Endoscopy 1993;7(3):177–81.
Nagy 1999 {published data only}
Nagy A, Pardavi G, Olah A. The role of diagnostic
laparoscopy in staging of pancreatic cancers. Acta chirurgica
Hungarica 1999;38(2):193–6.
Nieveen 1996 {published data only}
Nieveen van Dijkum EJ, Romijn MG, Terwee CB, van
der Meulen JH, de Haes JC, de Wit LT, et al. Value
of laparoscopic staging and palliative treatment of peri-
ampullary tumors; the Stentby Study. Nederlands Tijdschrift
Voor Geneeskunde 1996;140(50):2523–4.
Nieveen 1997 {published data only}
Nieveen van Dijkum EJ, de Wit LT, van Delden OM,
Rauws EA, van Lanschot JJ, Obertop H, et al. The
efficacy of laparoscopic staging in patients with upper
gastrointestinal tumors. Cancer 1997;79(7):1315–9.
Nieveen 1998 {published data only}
Nieveen van Dijkum EJ, Sturm PD, de Wit LT, Offerhaus
J, Obertop H, Gouma DJ. Cytology of peritoneal lavage
performed during staging laparoscopy for gastrointestinal
malignancies: is it useful?. Annals of Surgery 1998;228(6):
728–33.
Nieveen 1999 {published data only}
Nieveen van Dijkum EJ, de Wit LT, van Delden OM,
Kruyt PM, van Lanschot JJ, Rauws EA, et al. Staging
laparoscopy and laparoscopic ultrasonography in more than
400 patients with upper gastrointestinal carcinoma. Journal
of the American College of Surgeons 1999;189(5):459–65.
Nieveen 2000 {published data only}
Nieveen van Dijkum EJM, Romijn MG, Terwee CB, deWit
LT, van der Meulen JHP, Bossuyt PMM, et al. Randomised
study of laparoscopy and laparoscopic ultrasonography
(LLU) for periampullary tumors: Effect on staging and
treatment. European of Journal of Gastroenterology &
Hepatology 2000;12:A51.
Nieveen 2003 {published data only}
Nieveen van Dijkum EJM, Romijn MG, Terwee CB, De
Wit L, Van Der Meulen JHP, Lameris JS, et al. Laparoscopic
staging in patients with a peripancreatic tumour is of limited
value for diagnosis and palliative treatment. Nederlands
Tijdschrift Voor Geneeskunde 2003;147(36):1734–40.
Nieveen 2003a {published data only}
Nieveen van Dijkum EJM, Romijn MG, Terwee CB,
de Wit LT, Van der Meulen JHP, Lameris HS, et al.
Laparoscopic staging and subsequent palliation in patients
with peripancreatic carcinoma. Annals of Surgery 2003;237
(1):66–73.
Occelli 1999 {published data only}
Occelli G, Feroce A, Barrat C, Catheline JM, Champault G.
Staging of pancreatic cancer by laparoscopy and laparoscopic
ultrasonography. Chirurgia 1999;12(5):379–87.
Palanivelu 2001 {published data only}
Palanivelu C, Rajan PS, Kumar SK, Parthasarathi R. Role
of laparoscopy in pancreatic surgery. Journal International
Medical Sciences Academy 2001;14(3):137–9.
Parks 2000 {published data only}
Parks RW, Garden OJ. Staging laparoscopy for pancreatic
carcinoma: Can it be cost effective?. Asian Journal of Surgery
2000;23(3):187–90.
Pedrazzoli 1994 {published data only}
Pedrazzoli S, Sperti C, Pasquali C. Prediction of resectability
and of surgical risk in pancreatic carcinoma; conditioning
factors of survival after resective intervention. Chirurgia
Italiana 1994;46(2):30–8.
Pelton 1998 {published data only}
Pelton JJ. Routine diagnostic laparoscopy is unnecessary in
staging tumors of the pancreatic head. Southern Medical
Journal 1998;91(2):182–6.
Pietrabissa 1996 {published data only}
Pietrabissa A, Di Candio G, Giulianotti PC, Carobbi A,
Boggi U, Mosca F. Operative technique for the laparoscopic
staging of pancreatic malignancy. Minimally Invasive
Therapy & Allied Technologies 1996;5(3):274–80.
Pietrabissa 1996a {published data only}
Pietrabissa A, Di Candio G, Giulianotti PC, Mosca F.
Laparoscopic exposure of the pancreas and staging of
pancreatic cancer. Seminars in Laparoscopic Surgery 1996;3
(1):3–9.
Pietrabissa 1999 {published data only}
Pietrabissa A, Caramella D, Di Candio G, Carobbi A,
Boggi U, Rossi G, et al. Laparoscopy and laparoscopic
ultrasonography for staging pancreatic cancer: Critical
appraisal. World Journal of Surgery 1999;23(10):998–1003.
26Diagnostic accuracy of laparoscopy following computed tomography (CT) scanning for assessing the resectability with curative intent in
pancreatic and periampullary cancer (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Pisters 2001 {published data only}
Pisters PW, Lee JE, Vauthey JN, Charnsangavej C, Evans
DB. Laparoscopy in the staging of pancreatic cancer. British
Journal of Surgery 2001;88(3):325–37.
Potkonjak 1974 {published data only}
Potkonjak D, Filipovic Ristic B, Bjelic J. Comparison
of laparoscopic, surgical and histologic findings in the
diagnosis of malignant tumors of the pancreas. Medicinski
Arhiv 1974;28(2):195–8.
Ramshaw 1999 {published data only}
Ramshaw BJ, Esartia P, Mason EM, Wilson R, Duncan
T, White J, et al. Laparoscopy for diagnosis and staging
of malignancy. Seminars in Surgical Oncology 1999;16(4):
279–83.
Ribero 1994 {published data only}
Ribero F, Comotti F, Scaglia M, Ragusa L. Diagnostic-
operative laparoscopy. Our experience. Minerva Chirurgica
1994;49(6):533–7.
Rodgers 2003 {published data only}
Rodgers MS,Windsor JA, Koea JB,McCall JL. Laparoscopic
staging of upper gastrointestinal malignancy. ANJ Journal of
Surgery 2003;73(10):806–10.
Rothlin 1996 {published data only}
Röthlin M. Diagnostic laparoscopy and laparoscopic
ultrasonography: value of staging and assessment of
resectability of pancreatic carcinoma [Diagnostische
laparoskopie und laparoskopische sonographie:
stellenwert fur staging und resektabilitatsabklarung beim
pankreaskarzinom]. Swiss Surgery 1996;Suppl 4:25–8.
Rumstadt 1997 {published data only}
Rumstadt B, Schwab M, Schuster K, Hagmuller E, Trede
M. The role of laparoscopy in the preoperative staging of
pancreatic carcinoma. Journal of Gastrointestinal Surgery
1997;1(3):245–50.
Rumstadt 1997a {published data only}
Rumstadt B, Trede M. The role of laparoscopy and ultrafast
magnetic resonance imaging in the preoperative staging of
pancreatic carcinoma. Problems in General Surgery 1997;14
(2):59–64.
Saeian 1999 {published data only}
Saeian K, Rajender Reddy K. Staging laparoscopy: A peek
may save a cut. Endoscopy 1999;31(5):389–91.
Sand 1996 {published data only}
Sand J, Marnela K, Airo I, Nordback I. Staging of
abdominal cancer by local anesthesia outpatient laparoscopy.
Hepatogastroenterology 1996;43(12):1685–8.
Santoro 2012 {published data only}
Santoro PM, Abdel-Misih RZ, Petrelli NJ, Bennett JJ. Is
laparoscopy still needed for staging “resectable” pancreatic
cancer?. Annals of Surgical Oncology 2012;19:S162.
Sato 1985 {published data only}
Sato W. Laparoscopic biopsy of the pancreas.
Gastroenterological Endoscopy 1985;27(10):1940–9.
Satoi 2011 {published data only}
Satoi S, Yanagimoto H, Toyokawa H, Inoue K, Wada K,
Yamamoto T, et al. Selective use of staging laparoscopy
based on carbohydrate antigen 19-9 level and tumor size
in patients with radiographically defined potentially or
borderline resectable pancreatic cancer. Pancreas 2011;40
(3):426–32.
Schachter 1999 {published data only}
Schachter P, Avni Y, Rosen A, Czerniak A. Evaluation of
laparoscopy and laparoscopic ultrasound in diagnosis and
treatment of pancreatic lesions. Harefuah 1999;137(12):
593-7, 680.
Schmidt 1997 {published data only}
Schmidt J, Zirngibl H, Heinmoller E, Schuckel E, Jauch
KW. Laparoscopy and intraoperative peritoneal cytology
as predictors of operability in pancreatic carcinoma. Acta
Chirurgica Austriaca 1997;29(2):90–4.
Schmied 2000 {published data only}
Schmied BM, Z’Graggen K, Redaelli CA, Buchler MW.
Problems in staging of pancreatic and hepatobiliary
tumours. Annals of Oncology 2000;11 Suppl 3:161–4.
Schmielau 1997 {published data only}
Schmielau J, Schmiegel WH. Diagnosis of pancreatic
carcinoma. Medizinische Klinik 1997;92(9):525–6.
Schneider 2003 {published data only}
Schneider AR, Adamek HE, Layer G, Riemann JF, Arnold
JC. Staging of abdominal metastases in pancreatic carcinoma
by diagnostic laparoscopy and magnetic resonance imaging.
Zeitschrift für Gastroenterologie 2003;41(8):697–702.
Schnelldorfer 2014 {published data only}
Schnelldorfer T, Gagnon AI, Birkett RT, Reynolds G,
Murphy KM, Jenkins RL. Staging laparoscopy in pancreatic
cancer: A potential role for advanced laparoscopic
techniques. Journal of the American College of Surgeons 2014;
218(6):1201–6.
Schrenk 1994 {published data only}
Schrenk P, Woisetschlager R, Wayand WU, Rieger R,
Sulzbacher H. Diagnostic laparoscopy - a survey of 92
patients. American Journal of Surgery 1994;168(4):348–51.
Schrenk 1995 {published data only}
Schrenk P, Wayand W. Value of diagnostic laparoscopy in
abdominal malignancies. International Surgery 1995;80(4):
353–5.
Schwab 1996 {published data only}
Schwab M, Schwall G, Richter A, Trede M. Is diagnostic
laparoscopy a reliable addition to preoperative staging of
pancreatic carcinoma?. Langenbecks Archiv für Chirurgie.
Supplement. Kongressband 1996;113:565–7.
Sperlongano 2005 {published data only}
Sperlongano P, Avenia N. Does laparoscopy have a role in
pancreatic cancer?. Il Giornale di Chirurgia 2005;26(8-9):
293–4.
Sperlongano 2006 {published data only}
Sperlongano P, Pisaniello D, Piatto A, Parmeggiani D,
Sperlongano R, Avenia N, et al. The role of laparoscopy in
pancreatic surgery. Frontiers in Bioscience 2006;11:2203–5.
27Diagnostic accuracy of laparoscopy following computed tomography (CT) scanning for assessing the resectability with curative intent in
pancreatic and periampullary cancer (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Tang 2001 {published data only}
Tang CN, Siu WT, Li MKW. Use of diagnostic laparoscopy
and laparoscopic ultrasound in the management of upper
gastrointestinal malignancy. Annals of the College of Surgeons
of Hong Kong 2001;5(1):19–24.
Tapper 2011 {published data only}
Tapper E, Kalb B, Martin DR, Kooby D, Adsay NV,
Sarmiento JM. Staging laparoscopy for proximal pancreatic
cancer in a magnetic resonance imaging-driven practice:
what’s it worth?. HPB 2011;13(10):732–7.
Taylor 2001 {published data only}
Taylor AM, Roberts SA, Manson JM. Experience with
laparoscopic ultrasonography for defining tumour
resectability in carcinoma of the pancreatic head and
periampullary region. British Journal of Surgery 2001;88(8):
1077–83.
Terrosu 2000 {published data only}
Terrosu G, Cedolini C, Baccarani U, Vianello V, Bruschi F,
Uzzau A, et al. Echolaparoscopy in the staging of abdominal
neoplasms. Prospective study. Annali Italiani di Chirurgia
2000;71(2):199–204.
Thomson 2006 {published data only}
Thomson BN, Parks RW, Redhead DN, Welsh FK,
Madhavan KK, Wigmore SJ, et al. Refining the role of
laparoscopy and laparoscopic ultrasound in the staging of
presumed pancreatic head and ampullary tumours. British
Journal of Cancer 2006;94(2):213–7.
Tilleman 2004 {published data only}
Tilleman EH, Busch OR, Bemelman WA, van Gulik TM,
Obertop H, Gouma DJ. Diagnostic laparoscopy in staging
pancreatic carcinoma: developments during the past decade.
Journal of Hepato-Biliary-Pancreatic Surgery 2004;11(1):
11–6.
Tilleman 2004a {published data only}
Tilleman EH, Kuiken BW, Phoa SS, de Castro SM, Busch
OR, Obertop H, et al. Limitation of diagnostic laparoscopy
for patients with a periampullary carcinoma. European
Journal of Surgical Oncology 2004;30(6):658–62.
Toughrai 2013 {published data only}
Toughrai I, Ait Laalim S, Ibn Majdoub K, Mazaz K.
Resectability evaluation in pancreatic cancer. Presse Medicale
2013;42(9 Pt 1):1171–5.
van Delden 1996 {published data only}
van Delden OM, Smits NJ, Bemelman WA, de Wit LT,
Gouma DJ, Reeders JW. Comparison of laparoscopic and
transabdominal ultrasonography in staging of cancer of the
pancreatic head region. Journal of Ultrasound in Medicine
1996;15(3):207–12.
van Dijkum 1997 {published data only}
van Dijkum E, deWit LT, van Delden OM, Rauws EAJ, van
Lanschot JJB, Obertop H, et al. The efficacy of laparoscopic
staging in patients with upper gastrointestinal tumors.
Cancer 1997;79(7):1315–9.
Velanovich 1998 {published data only}
Velanovich V. Staging laparoscopy in the management
of intra-abdominal malignancies. Surgery 1998;124(4):
773–81.
Velanovich 2004 {published data only}
Velanovich V. The effects of staging laparoscopy on trocar
site and peritoneal recurrence of pancreatic cancer. Surgical
Endoscopy 2004;18(2):310–3.
Velasco 2000 {published data only}
Velasco JM, Rossi H, Hieken TJ, Fernandez M.
Laparoscopic ultrasound enhances diagnostic laparoscopy
in the staging of intra-abdominal neoplasms. American
Surgeon 2000;66(4):407–11.
Vollmer 2002 {published data only}
Vollmer CM, Drebin JA, Middleton WD, Teefey SA,
Linehan DC, Soper NJ, et al. Utility of staging laparoscopy
in subsets of peripancreatic and biliary malignancies. Annals
of Surgery 2002;235(1):1–7.
Warshaw 1990 {published data only}
Warshaw AL, Gu ZY. Laparoscopy for preoperative staging
of malignant tumors of the foregut. Esophageal, gastric,
and pancreatic cancer. Problems in General Surgery 1990;7
(Special Issue):65–74.
Warshaw 1990a {published data only}
Warshaw AL, Gu ZY, Wittenberg J, Waltman AC.
Preoperative staging and assessment of resectability of
pancreatic cancer. Archives of Surgery 1990;125(2):230–3.
Watanabe 1993 {published data only}
Watanabe M, Akagi S, Uchida Y, Kohge N, Fukumoto S.
Role of laparoscopy in the diagnosis of pancreatic cancer.
Digestive Endoscopy 1993;5(1):55–61.
Weiner 1995 {published data only}
Weiner R, Winterberg U, Bockhorn H. Laparoscopic
staging of gastrointestinal tumors. Zentralblatt für Chirurgie
1995;120(5):350–2.
White 2001 {published data only}
White RR, Paulson EK, Freed KS, KeoganMT, Hurwitz HI,
Lee C, et al. Staging of pancreatic cancer before and after
neoadjuvant chemoradiation. Journal of Gastrointestinal
Surgery 2001;5(6):626–33.
White 2004 {published data only}
White RR, Pappas TN. Laparoscopic staging for
hepatobiliary carcinoma. Journal of Gastrointestinal Surgery
2004;8(8):920–2.
White 2008 {published data only}
White R, Winston C, Gonen M, D’Angelica M, Jarnagin
W, Fong Y, et al. Current utility of staging laparoscopy
for pancreatic and peripancreatic neoplasms. Journal of the
American College of Surgeons 2008;206(3):445–50.
Wilson 2010 {published data only}
Wilson CH, White SA. Single-centre experience of
laparoscopic pancreatic surgery. British Journal of Surgery.
2010;97(12):1891–2.
28Diagnostic accuracy of laparoscopy following computed tomography (CT) scanning for assessing the resectability with curative intent in
pancreatic and periampullary cancer (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Yoshida 2002 {published data only}
Yoshida T, Matsumoto T, Morii Y, Ishio T, Kitano
S, Yamada Y, et al. Staging with helical computed
tomography and laparoscopy in pancreatic head cancer.
Hepatogastroenterology 2002;49(47):1428–31.
Zhao 2003 {published data only}
Zhao ZW, He JY, Tan G, Wang HJ, Li KJ. Laparoscopy and
laparoscopic ultrasonography in judging the resectability of
pancreatic head cancer. Hepatobiliary & Pancreatic Diseases
International 2003;2(4):609–11.
Additional references
Abrams 2009
Abrams RA, Lowy AM, O’Reilly EM, Wolff RA, Picozzi
VJ, Pisters PW. Combined modality treatment of resectable
and borderline resectable pancreas cancer: Expert consensus
statement. Annals of Surgical Oncology 2009;16(7):1751–6.
Azevedo 2009
Azevedo JL, Azevedo OC, Miyahira SA, Miguel GP, Becker
OM Jr, Hypolito OH, et al. Injuries caused by Veress needle
insertion for creation of pneumoperitoneum: a systematic
literature review. Surgical Endoscopy 2009;23(7):1428–32.
Chang 2009
Chang L, Stefanidis D, Richardson WS, Earle DB, Fanelli
RD. The role of staging laparoscopy for intraabdominal
cancers: an evidence-based review. Surgical Endoscopy 2009;
23(2):231–41.
Conlon 1996
Conlon KC, Klimstra DS, Brennan MF. Long-term
survival after curative resection for pancreatic ductal
adenocarcinoma. Clinicopathologic analysis of 5-year
survivors. Annals of Surgery 1996;223(3):273–9.
Eloubeidi 2001
Eloubeidi MA, Wade SB, Provenzale D. Factors
associated with acceptance and full publication of GI
endoscopic research originally published in abstract form.
Gastrointestinal Endoscopy 2001;53(3):275–82.
Engelken 2003
Engelken FJ, Bettschart V, Rahman MQ, Parks RW, Garden
OJ. Prognostic factors in the palliation of pancreatic cancer.
European Journal of Surgical Oncology 2003;29(4):368–73.
Gurusamy 2015
Gurusamy KS, Davidson BR. Diagnostic accuracy
of different imaging modalities following computed
tomography (CT) scanning for assessing the resectability
with curative intent in pancreatic and periampullary cancer.
Cochrane Database of Systematic Reviews 2015, Issue 2.
[DOI: 10.1002/14651858.CD011515]
Klempnauer 1995
Klempnauer J, Ridder GJ, Pichlmayr R. Prognostic factors
after resection of ampullary carcinoma: multivariate survival
analysis in comparison with ductal cancer of the pancreatic
head. British Journal of Surgery 1995;82(12):1686–91.
Lillemoe 1999
Lillemoe KD, Cameron JL, Hardacre JM, Sohn TA, Sauter
PK, Coleman J, et al. Is prophylactic gastrojejunostomy
indicated for unresectable periampullary cancer? A
prospective randomized trial. Annals of Surgery 1999;230
(3):322–8.
Mayo 2009
Mayo SC, Austin DF, Sheppard BC, Mori M, Shipley DK,
Billingsley KG. Evolving preoperative evaluation of patients
with pancreatic cancer: does laparoscopy have a role in the
current era?. Journal of the American College of Surgeons
2009;208(1):87–95.
Michelassi 1989
Michelassi F, Erroi F, Dawson PJ, Pietrabissa A, Noda
S, Handcock M, et al. Experience with 647 consecutive
tumors of the duodenum, ampulla, head of the pancreas,
and distal common bile duct. Annals of Surgery 1989;210
(4):544–54.
National Cancer Institute 2011a
National Cancer Institute (US National Institutes of
Health). Dictionary of cancer terms. Periampullary
cancer. http://www.cancer.gov/dictionary/?CdrID=543930
(accessed on 17 April 2011).
National Cancer Institute 2011b
National Cancer Institute (US National Institutes of
Health). Dictionary of cancer terms. CT scan. http://
www.cancer.gov/dictionary?CdrID=46033 (accessed on 17
April 2011).
Sampson 2008
Sampson M, Shojania KG, McGowan J, Daniel R, Rader
T, Iansavichene AE, et al. Surveillance search techniques
identified the need to update systematic reviews. Journal of
Clinical Epidemiology 2008;61(8):755–62.
Shahrudin 1997
Shahrudin MD. Carcinoma of the pancreas: resection
outcome at the University Hospital Kuala Lumpur.
International Surgery 1997;82(3):269–74.
Smith 2008
Smith RA, Bosonnet L, Ghaneh P, Sutton R, Evans J,
Healey P, et al. The platelet-lymphocyte ratio improves the
predictive value of serum CA19-9 levels in determining
patient selection for staging laparoscopy in suspected
periampullary cancer. Surgery 2008;143(5):658–66.
Whiting 2011
Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks
JJ, Reitsma JB, et al. QUADAS-2: a revised tool for the
quality assessment of diagnostic accuracy studies. Annals of
Internal Medicine 2011;155(8):529–36.
Yeo 2002
Yeo CJ, Cameron JL, Lillemoe KD, Sohn TA, Campbell
KA, Sauter PK, et al. Pancreaticoduodenectomy with or
without distal gastrectomy and extended retroperitoneal
lymphadenectomy for periampullary adenocarcinoma,
part 2: randomized controlled trial evaluating survival,
29Diagnostic accuracy of laparoscopy following computed tomography (CT) scanning for assessing the resectability with curative intent in
pancreatic and periampullary cancer (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
morbidity, and mortality. Annals of Surgery 2002;236(3):
355–66.
References to other published versions of this review
Allen 2013
Allen VB, Gurusamy KS, Takwoingi Y, Kalia A, Davidson
BR. Diagnostic accuracy of laparoscopy following computed
tomography (CT) scanning for assessing the resectability
with curative intent in pancreatic and periampullary cancer.
Cochrane Database of Systematic Reviews 2013, Issue 11.
[DOI: 10.1002/14651858.CD009323.pub2]
∗ Indicates the major publication for the study
30Diagnostic accuracy of laparoscopy following computed tomography (CT) scanning for assessing the resectability with curative intent in
pancreatic and periampullary cancer (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Ahmed 2006
Study characteristics
Patient sampling Sample size: 37
Females: Not stated
Age: Not stated
Patient characteristics and set-
ting
Patients with potentially resectable, histologically confirmed pancreatic adenocarcinoma (after CT
scan)
Setting: Surgical centre in the USA
Index tests Diagnostic laparoscopy
Criteria for positive diagnosis: Tumours were considered locally advanced and unresectable if la-
paroscopic examination revealed peritoneal or liver metastasis, coeliac artery or para-aortic lymph
node involvement, or tumour invasion or encasement of the coeliac axis or hepatic artery
Target condition and reference
standard(s)
Target condition: Unresectability
Reference standard: Laparotomy for patients with no evidence of metastases on laparoscopy; biopsy
with histolopathological confirmation of spread for patients with suspected metastases
Criteria for positive diagnosis: Tumours were considered locally advanced and unresectable if la-
paroscopic examination revealed peritoneal or liver metastasis, coeliac artery or para-aortic lymph
node involvement, or tumour invasion or encasement of the coeliac axis or hepatic artery
Flow and timing Number of indeterminates for whom the results of reference standard were available: Not stated
Number of patients who were excluded from the analysis: 22 (37.3%)
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
No
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Ahmed 2006 (Continued)
Low
DOMAIN 2: Index Test All tests
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Unclear
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
No
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
No
Were all patients included in the
analysis?
No
Arnold 1999
Study characteristics
Patient sampling Sample size: 33
Females: Not stated
Age: Not stated
Patient characteristics and set-
ting
Patients with potentially resectable pancreatic adenocarcinoma (after CT scan)
Setting: Germany (setting not clear)
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Arnold 1999 (Continued)
Index tests Diagnostic laparoscopy
Criteria for positive diagnosis: Biopsies of lesions suspicious of metastases
Target condition and reference
standard(s)
Target condition: Unresectability
Reference standard: Laparotomy for patients with no evidence of metastases on laparoscopy; biopsy
with histolopathological confirmation of spread for patients with suspected metastases
Criteria for positive diagnosis: Not stated
Flow and timing Number of indeterminates for whom the results of reference standard were available: Not stated
Number of patients who were excluded from the analysis: 14 (29.8%)
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
No
Low
DOMAIN 2: Index Test All tests
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Unclear
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Arnold 1999 (Continued)
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
No
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
No
Were all patients included in the
analysis?
No
Arnold 2001a
Study characteristics
Patient sampling Sample size: 61
Females: Not stated
Age: Not stated
Patient characteristics and set-
ting
Patients with potentially resectable pancreatic adenocarcinoma (after CT scan)
Setting: Germany (setting not clear)
Index tests Diagnostic laparoscopy
Criteria for positive diagnosis: Biopsies of lesions suspicious of metastases
Target condition and reference
standard(s)
Target condition: Unresectability
Reference standard: Laparotomy for patients with no evidence of metastases on laparoscopy; biopsy
with histolopathological confirmation of spread for patients with suspected metastases
Criteria for positive diagnosis: Not stated
Flow and timing Number of indeterminates for whom the results of reference standard were available: Not stated
Number of patients who were excluded from the analysis: Not stated
Comparative
Notes
Methodological quality
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Arnold 2001a (Continued)
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Low
DOMAIN 2: Index Test All tests
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Unclear
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
No
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
No
Were all patients included in the
analysis?
Unclear
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Arnold 2001a (Continued)
Beenen 2014
Study characteristics
Patient sampling Sample size: 131
Females: Not stated
Age: Not stated
Patient characteristics and set-
ting
Patients with CT and ultrasound resectable periampullary cancer
Setting: Secondary/tertiary care, the Netherlands
Index tests Diagnostic laparoscopy
Criteria for positive diagnosis: Biopsy confirmation of suspicious lesions
Target condition and reference
standard(s)
Target condition: Unresectability
Reference standard: Laparotomy
Criteria for positive diagnosis: Locally advanced pancreatic cancer or metastatic pancreatic cancer
Flow and timing Number of indeterminates for whom the results of reference standard were available: 0
Number of patients who were excluded from the analysis: 74 (36.1%)
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
No
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
High
DOMAIN 2: Index Test All tests
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Beenen 2014 (Continued)
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
No
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Unclear
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
No
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
Brooks 2002
Study characteristics
Patient sampling Sample size: 144
Females: Not stated
Age: Not stated
Patient characteristics and set-
ting
Patients with potentially resectable periampullary carcinoma other than pancreatic cancer
Setting: Surgical centre in the USA
Index tests Diagnostic laparoscopy
Criteria for positive diagnosis: Patients were deemed unresectable at diagnostic laparoscopy or
laparotomy if they were found to have histologically proved peritoneal or hepatic metastases, distant
nodal involvement, arterial involvement, or local extension outside the resection field
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Brooks 2002 (Continued)
Target condition and reference
standard(s)
Target condition: Unresectability
Reference standard: Laparotomy for patients with no evidence of metastases on laparoscopy; biopsy
with histolopathological confirmation of spread for patients with suspected metastases
Criteria for positive diagnosis: Patients were deemed unresectable at diagnostic laparoscopy or
laparotomy if they were found to have histologically proven peritoneal or hepatic metastases, distant
nodal involvement, arterial involvement, or local extension outside the resection field
Flow and timing Number of indeterminates for whom the results of reference standard were available: 10 (6.9%)
Number of patients who were excluded from the analysis: Not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Low
DOMAIN 2: Index Test All tests
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Unclear
Were the reference standard re-
sults
No
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Brooks 2002 (Continued)
interpreted without knowledge
of the results of the index tests?
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
No
Were all patients included in the
analysis?
Unclear
Contreras 2009
Study characteristics
Patient sampling Sample size: 25
Females: 12 (32.5%)
Age: 68 years
Patient characteristics and set-
ting
Patients with potentially resectable pancreatic adenocarcinoma (after CT scan)
Setting: Surgical referral centre in the USA
Index tests Diagnostic laparoscopy
Criteria for positive diagnosis: Biopsies of lesions suspicious of metastases
Target condition and reference
standard(s)
Target condition: Unresectability
Reference standard: Laparotomy for patients with no evidence of metastases on laparoscopy; biopsy
with histolopathological confirmation of spread for patients with suspected metastases
Criteria for positive diagnosis: Not stated
Flow and timing Number of indeterminates for whom the results of reference standard were available: Not stated
Number of patients who were excluded from the analysis: 52 (67.5%)
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
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DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
No
Low
DOMAIN 2: Index Test All tests
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Unclear
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
No
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
No
Were all patients included in the
analysis?
No
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Fernandez-Castillo 1995
Study characteristics
Patient sampling Sample size: 109
Females: Not stated
Age: Not stated
Patient characteristics and set-
ting
Patients with potentially resectable pancreatic adenocarcinoma (on CT scan) without gastric outlet
obstruction
Setting: Surgical centre in the USA
Index tests Diagnostic laparoscopy
Criteria for positive diagnosis: Biopsies of lesions suspicious of metastases
Target condition and reference
standard(s)
Target condition: Unresectability
Reference standard: Laparotomy for patients with no evidence of metastases on laparoscopy; biopsy
with histolopathological confirmation of spread for patients with suspected metastases
Criteria for positive diagnosis: Not stated
Flow and timing Number of indeterminates for whom the results of reference standard were available: not stated
Number of patients who were excluded from the analysis: 5 (4.2%)
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
No
Low
DOMAIN 2: Index Test All tests
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
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Fernandez-Castillo 1995 (Continued)
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Unclear
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
No
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
No
Were all patients included in the
analysis?
No
John 1995
Study characteristics
Patient sampling Sample size: 40
Females: 22 (100%)
Age: 59 years
Patient characteristics and set-
ting
Patients with potentially resectable pancreatic or periampullary carcinoma
Setting: Tertiary referral centre in the UK
Index tests Diagnostic laparoscopy
Criteria for positive diagnosis: Biopsies of lesions suspicious of metastases
Target condition and reference
standard(s)
Target condition: Unresectability
Reference standard: Laparotomy for patients with no evidence of metastases on laparoscopy; biopsy
with histolopathological confirmation of spread for patients with suspected metastases
Criteria for positive diagnosis: The criteria used to define primary tumour advancement and locore-
gional unresectability were as follows:
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1. tumour size of 5 cm or greater;
2. extrapancreatic invasionof adjacent tissues (i.e. duodenum, stomach, commonbile duct, retroperi-
toneum); and
3. occlusion or stenosis of the portal or superior mesenteric veins, or major branches of the coeliac
trunk or superior mesenteric artery
Flow and timing Number of indeterminates for whom the results of reference standard were available: Not stated
Number of patients who were excluded from the analysis: Not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Low
DOMAIN 2: Index Test All tests
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Unclear
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
No
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Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
No
Were all patients included in the
analysis?
Unclear
Kishiwada 2002
Study characteristics
Patient sampling Sample size: 16
Females: Not stated
Age: Not stated
Patient characteristics and set-
ting
Patients with potentially resectable pancreatic cancer (only patients with tumours more than 2 cm
in diameter were subject to diagnostic laparoscopy)
Setting: Surgical centre in Japan
Index tests Diagnostic laparoscopy
Criteria for positive diagnosis: Biopsies of lesions suspicious of metastases
Target condition and reference
standard(s)
Target condition: Unresectability
Reference standard: Laparotomy for patients with no evidence of metastases on laparoscopy; biopsy
with histolopathological confirmation of spread for patients with suspected metastases
Criteria for positive diagnosis: Not stated
Flow and timing Number of indeterminates for whom the results of reference standard were available: Not stated
Number of patients who were excluded from the analysis: Not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
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Was a consecutive or random
sample of patients enrolled?
No
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
High
DOMAIN 2: Index Test All tests
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Unclear
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
No
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
No
Were all patients included in the
analysis?
No
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Lavy 2012
Study characteristics
Patient sampling Sample size: 52
Females: Not stated
Age: Not stated
Patient characteristics and set-
ting
Patients with potentially resectable pancreatic adenocarcinoma (after CT scan and EUS)
Setting: Surgical centre in Israel
Index tests Diagnostic laparoscopy
Criteria for positive diagnosis: Biopsies of lesions suspicious of metastases
Target condition and reference
standard(s)
Target condition: Unresectability
Reference standard: Laparotomy for patients with no evidence of metastases on laparoscopy; biopsy
with histopathological confirmation of spread for patients with suspected metastases
Criteria for positive diagnosis: Not stated
Flow and timing Number of indeterminates for whom the results of reference standard were available: Not stated
Number of patients who were excluded from the analysis: Not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low
DOMAIN 2: Index Test All tests
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
Low
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DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Unclear
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
No
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
No
Were all patients included in the
analysis?
Unclear
Menack 2001
Study characteristics
Patient sampling Sample size: 27
Females: 10 (100%)
Age: 66 years
Patient characteristics and set-
ting
Patients with potentially resectable pancreatic or periampullary cancer (after CT scan)
Setting: Surgical centre in the USA
Index tests Diagnostic laparoscopy
Criteria for positive diagnosis: Biopsies of lesions suspicious of metastases
Target condition and reference
standard(s)
Target condition: Unresectability
Reference standard: Laparotomy for patients with no evidence of metastases on laparoscopy; biopsy
with histolopathological confirmation of spread for patients with suspected metastases
Criteria for positive diagnosis: Patients were considered unresectable if they had histologically proven
metastatic disease or carcinomatosis
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Flow and timing Number of indeterminates for whom the results of reference standard were available: Not stated
Number of patients who were excluded from the analysis: Not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Low
DOMAIN 2: Index Test All tests
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Unclear
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
No
Low
DOMAIN 4: Flow and Timing
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Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
No
Were all patients included in the
analysis?
Unclear
Merchant 1998
Study characteristics
Patient sampling Sample size: 303
Females: Not stated
Age: Not stated
Patient characteristics and set-
ting
Patients with potentially resectable pancreatic or periampullary cancer (after CT scan)
Setting: Surgical centre in the USA
Index tests Diagnostic laparoscopy
Criteria for positive diagnosis: Biopsies of lesions suspicious of metastases
Target condition and reference
standard(s)
Target condition: Unresectability
Reference standard: Laparotomy for patients with no evidence of metastases on laparoscopy; biopsy
with histolopathological confirmation of spread for patients with suspected metastases
Criteria for positive diagnosis: Unresectable if one or more of the following were confirmed
histopathologically:
1. hepatic, serosal/peritoneal, or omental metastases;
2. extrapancreatic extension of tumour (i.e. mesocolic involvement);
3. celiac or high portal nodal involvement by tumour; and
4. invasion or encasement of the coeliac axis, hepatic artery, or superior mesenteric artery
Flow and timing Number of indeterminates for whom the results of reference standard were available: Not stated
Number of patients who were excluded from the analysis: 36 (10.6%)
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
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Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
No
Low
DOMAIN 2: Index Test All tests
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Unclear
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
No
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
No
Were all patients included in the
analysis?
Unclear
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Reddy 1999
Study characteristics
Patient sampling Sample size: 98
Females: 47 (49%)
Age: 65 years
Patient characteristics and set-
ting
Patients with potentially resectable pancreatic cancer (on CT scan)
Setting: Surgical centre in the USA
Index tests Diagnostic laparoscopy
Criteria for positive diagnosis: Biopsies of lesions suspicious of metastases
Target condition and reference
standard(s)
Target condition: Unresectability
Reference standard: Laparotomy for patients with no evidence of metastases on laparoscopy; biopsy
with histolopathological confirmation of spread for patients with suspected metastases
Criteria for positive diagnosis: Not stated
Flow and timing Number of indeterminates for whom the results of reference standard were available: Not stated
Number of patients who were excluded from the analysis: 1 (1%)
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
No
Low
DOMAIN 2: Index Test All tests
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
Low
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DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Unclear
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
No
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
No
Were all patients included in the
analysis?
No
Reed 1997
Study characteristics
Patient sampling Sample size: 11
Females: Not stated
Age: Not stated
Patient characteristics and set-
ting
Patients with potentially resectable pancreatic cancer (on CT scan)
Setting: Surgical centre in the USA
Index tests Diagnostic laparoscopy
Criteria for positive diagnosis: Biopsies of lesions suspicious of metastases
Target condition and reference
standard(s)
Target condition: Unresectability
Reference standard: Laparotomy for patients with no evidence of metastases on laparoscopy; biopsy
with histolopathological confirmation of spread for patients with suspected metastases
Criteria for positive diagnosis: Not stated
Flow and timing Number of indeterminates for whom the results of reference standard were available: Not stated
Number of patients who were excluded from the analysis: Not stated
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Reed 1997 (Continued)
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Low
DOMAIN 2: Index Test All tests
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Unclear
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
No
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
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Did all patients receive the same
reference standard?
No
Were all patients included in the
analysis?
Unclear
Shah 2008
Study characteristics
Patient sampling Sample size: 19
Females: Not stated
Age: Not stated
Patient characteristics and set-
ting
Patients with potentially resectable pancreatic cancer (on CT scan)
Setting: Surgical centre in the USA
Index tests Diagnostic laparoscopy
Criteria for positive diagnosis: Biopsies of lesions suspicious of metastases
Target condition and reference
standard(s)
Target condition: Unresectability
Reference standard: Laparotomy for patients with no evidence of metastases on laparoscopy; biopsy
with histolopathological confirmation of spread for patients with suspected metastases
Criteria for positive diagnosis: Not stated
Flow and timing Number of indeterminates for whom the results of reference standard were available: Not stated
Number of patients who were excluded from the analysis: 30 (61.2%)
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
No
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Low
DOMAIN 2: Index Test All tests
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Unclear
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
No
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
No
Were all patients included in the
analysis?
No
Warshaw 1986
Study characteristics
Patient sampling Sample size: 40
Females: Not stated
Age: Not stated
Patient characteristics and set-
ting
Patients with potentially resectable pancreatic adenocarcinoma (after CT scan)
Setting: Surgical centre in the USA
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Index tests Diagnostic laparoscopy
Criteria for positive diagnosis: Biopsies of lesions suspicious of metastases
Target condition and reference
standard(s)
Target condition: Unresectability
Reference standard: Laparotomy for patients with no evidence of metastases on laparoscopy; biopsy
with histolopathological confirmation of spread for patients with suspected metastases
Criteria for positive diagnosis: Not stated
Flow and timing Number of indeterminates for whom the results of reference standard were available: Not stated
Number of patients who were excluded from the analysis: Not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Low
DOMAIN 2: Index Test All tests
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Unclear
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Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
No
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
No
Were all patients included in the
analysis?
No
CT: computed tomography
EUS: endoscopic ultrasound
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Abdalla 2003 Insufficient diagnostic test accuracy data available for diagnostic laparoscopy
Adisa 2014 No separate data available for pancreatic or periampullary cancers
Alexakis 2015 No diagnostic test accuracy data available for diagnostic laparoscopy
Altieri 1982 Wrong target condition
Andren-Sandberg 1998 Includes participants who were considered to be unresectable by CT scan
Arnold 2001 Not a diagnostic accuracy study
Atanov 1972 No separate data available for pancreatic or periampullary cancers
Awad 1997 Includes participants who were considered to be unresectable by CT scan
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Baghbanian 2013 Not clear whether histopathological confirmation of metastasis was obtained
Baghbanian 2014 Not clear whether histopathological confirmation of metastasis was obtained
Balcom 2000 Not a diagnostic accuracy study
Barabino 2011 No diagnostic test accuracy data available for diagnostic laparoscopy
Barrat 1998 No separate data available for pancreatic or periampullary cancers
Barreiro 2002 Not a diagnostic accuracy study
Barthet 2007 Not a diagnostic accuracy study
Baumgarten 1984 No diagnostic test accuracy data available for diagnostic laparoscopy
Beger 1997 Not a diagnostic accuracy study
Belagyi 2000 Not a diagnostic accuracy study
Bemelman 1995 No diagnostic test accuracy data available for diagnostic laparoscopy
Bohmig 2001 Not a diagnostic accuracy study
Borbath 2005 No diagnostic test accuracy data available for diagnostic laparoscopy
Boselli 2000 No diagnostic test accuracy data available for diagnostic laparoscopy
Bottger 1998 No diagnostic test accuracy data available for diagnostic laparoscopy
Boyce 1992 Not a diagnostic accuracy study
Caldironi 1996 The proportion of participants who were considered to be resectable after CT scan is not known
Callery 1997 No separate data available for pancreatic or periampullary carcinoma
Callery 2009 Not a diagnostic accuracy study
Camacho 2005 Not a diagnostic accuracy study
Carmichael 1995 Not a diagnostic accuracy study
Carpenter 1996 Not a diagnostic accuracy study
Catheline 1998 No diagnostic test accuracy data available for diagnostic laparoscopy
58Diagnostic accuracy of laparoscopy following computed tomography (CT) scanning for assessing the resectability with curative intent in
pancreatic and periampullary cancer (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
(Continued)
Catheline 1999 No diagnostic test accuracy data available for diagnostic laparoscopy
Chambon 1995 No diagnostic test accuracy data available for diagnostic laparoscopy
Champault 1996 No diagnostic test accuracy data available for diagnostic laparoscopy
Champault 1997 No diagnostic test accuracy data available for diagnostic laparoscopy
Charukhchyan 1998 No diagnostic test accuracy data available for diagnostic laparoscopy
Cipollone 2012 No diagnostic test accuracy data available for diagnostic laparoscopy
Conlon 1997 The number of participants with pancreatic or periampullary cancers is not stated
Conlon 1999 Not a diagnostic accuracy study
Conlon 2002 Not a diagnostic accuracy study
Connor 2004 Not a diagnostic accuracy study
Croome 2009 Insufficient diagnostic test accuracy data available for diagnostic laparoscopy
Croome 2010 Insufficient diagnostic test accuracy data available for diagnostic laparoscopy
Cuesta 1993 No diagnostic test accuracy data available for diagnostic laparoscopy
Cuschieri 1978 No diagnostic test accuracy data available for diagnostic laparoscopy
Cuschieri 1988 The proportion of participants who were considered to be resectable after CT scan is not known
D’Angelica 2003 Wrong target condition
Dadan 1980 Insufficient diagnostic test accuracy data available for diagnostic laparoscopy
Doran 2004 No diagnostic test accuracy data available for diagnostic laparoscopy
Doucas 2007 No diagnostic test accuracy data available for diagnostic laparoscopy
Duffy 2008 Not a diagnostic accuracy study
Durup Scheel-Hincke 1999 No diagnostic test accuracy data available for diagnostic laparoscopy
Eigler 1999 Not a diagnostic accuracy study
Ellsmere 2005 No diagnostic test accuracy data available for diagnostic laparoscopy
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Enestvedt 2008 Includes participants who were considered to be unresectable by CT scan
Fernandez-del Castillo 1994 Not a diagnostic accuracy study
Fernandez-del Castillo 1998 Not a diagnostic accuracy study
Ferrone 2006 No diagnostic test accuracy data available for diagnostic laparoscopy
Feussner 2000 No separate data available for pancreatic or periampullary cancer
Fevery 1985 No separate data available for pancreatic or periampullary cancer
Fockens 1993 Not a diagnostic accuracy study
Friess 1997 No diagnostic test accuracy data available for diagnostic laparoscopy
Friess 1998 No separate data available for pancreatic or periampullary cancer
Fristrup 2006 No diagnostic test accuracy data available for diagnostic laparoscopy
Fukumoto 1989 No separate data available for pancreatic or periampullary cancer
Garcea 2012 No diagnostic test accuracy data available for diagnostic laparoscopy
Garofalo 2009 No diagnostic test accuracy data available for diagnostic laparoscopy
Gouma 1996 No diagnostic test accuracy data available for diagnostic laparoscopy
Gouma 1999 Not a diagnostic accuracy study
Gouma 2002 Not a diagnostic accuracy study
Hann 1997 No diagnostic test accuracy data available for diagnostic laparoscopy
Hashimoto 2015 In this study, all 11 participants who underwent diagnostic laparoscopy and laparotomy had resectable
pancreatic cancers. There were therefore no true positives and false negatives for estimation of sensi-
tivity, and this study was excluded
Healthcare 1999 Not a diagnostic accuracy study
Heger 2008 Not a diagnostic accuracy study
Hernandezguio 1965 Not a diagnostic accuracy study
Herrera 2003 No diagnostic test accuracy data available for diagnostic laparoscopy
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Hidalgo 2004 Not a diagnostic accuracy study
Hohenberger 2000 Not a diagnostic accuracy study
Holzman 1997 No diagnostic test accuracy data available for diagnostic laparoscopy
Hunerbein 1999 Not a diagnostic accuracy study
Hunerbein 2001 No diagnostic test accuracy data available for diagnostic laparoscopy
Ialongo 2010 Not a diagnostic accuracy study
Ialongo 2015 Not a diagnostic accuracy study
Ido 1982 No diagnostic test accuracy data available for diagnostic laparoscopy
Ihse 1984 Not a diagnostic accuracy study
Ishida 1983 No diagnostic test accuracy data available for diagnostic laparoscopy
Ishida 1984 Wrong target condition
Ivanov 1989 No diagnostic test accuracy data available for diagnostic laparoscopy
Jackowski 1997 No diagnostic test accuracy data available for diagnostic laparoscopy
Jakobs 1999 Not a diagnostic accuracy study
Jarnagin 2000 Wrong target condition
Jayakrishnan 2015 Not a diagnostic accuracy study
Jerby 1998 Not a diagnostic accuracy study
Jimenez 2000 Not a diagnostic accuracy study
Jimenez 2000a No diagnostic test accuracy data available for diagnostic laparoscopy
John 1999 No diagnostic test accuracy data available for diagnostic laparoscopy
Juzkow 1996 Not a diagnostic accuracy study
Kadar 1997 No diagnostic test accuracy data available for diagnostic laparoscopy
Kanazawa 1983 No separate data available for pancreatic or periampullary cancer
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Kaplan 1979 Not a diagnostic accuracy study
Karachristos 2005 Intervention between index test and reference standard
Kellokumpu 1996 Not a diagnostic accuracy study
Kelly 2009 No diagnostic test accuracy data available for diagnostic laparoscopy
Khamdanov 1983 Not a diagnostic accuracy study
Kiyonaga 1982 Wrong target condition
Klingler 2000 No diagnostic test accuracy data available for diagnostic laparoscopy
Krahenbuhl 1997 Not a diagnostic accuracy study
Krustev 1998 No diagnostic test accuracy data available for diagnostic laparoscopy
Kubyshkin 2000 No diagnostic test accuracy data available for diagnostic laparoscopy
Kuster 1967 No diagnostic test accuracy data available for diagnostic laparoscopy
Kwon 2002 No diagnostic test accuracy data available for diagnostic laparoscopy
Lavonius 2001 Includes participants who were considered to be unresectable by CT scan
Lightdale 1992 Not a diagnostic accuracy study
Liu 2004 Not a diagnostic accuracy study
Long 2005 Not a diagnostic accuracy study
Luque-de Leon 1998 No diagnostic test accuracy data available for diagnostic laparoscopy
Luque-de Leon 1999 No diagnostic test accuracy data available for diagnostic laparoscopy
Macutkiewicz 2009 No diagnostic test accuracy data available for diagnostic laparoscopy
Madsen 1994 No separate data available for pancreatic or periampullary cancer
Madsen 1994a No separate data available for pancreatic or periampullary cancer
Maire 2004 No diagnostic test accuracy data available for diagnostic laparoscopy
Maithel 2008 No diagnostic test accuracy data available for diagnostic laparoscopy
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Meduri 1994 The proportion of participants who were considered to be resectable after CT scan is not known
Metcalfe 2003 Not a diagnostic accuracy study
Meyer 1973 No diagnostic test accuracy data available for diagnostic laparoscopy
Misra 2012 No diagnostic test accuracy data available for diagnostic laparoscopy
Molnar 2010 The proportion of patients who were considered to be resectable after CT scan is not known
Morak 2009 No diagnostic test accuracy data available for diagnostic laparoscopy
Morganti 2005 No diagnostic test accuracy data available for diagnostic laparoscopy
Mortensen 1996 No diagnostic test accuracy data available for diagnostic laparoscopy
Muniraj 2013 Not a diagnostic accuracy study
Muntean 2009 No diagnostic test accuracy data available for diagnostic laparoscopy
Munteanu 2010 No diagnostic test accuracy data available for diagnostic laparoscopy
Murugiah 1993 The proportion of participants who were considered to be resectable after CT scan is not known
Nagy 1999 Not a diagnostic accuracy study
Nieveen 1996 No diagnostic test accuracy data available for diagnostic laparoscopy
Nieveen 1997 No diagnostic test accuracy data available for diagnostic laparoscopy
Nieveen 1998 No diagnostic test accuracy data available for diagnostic laparoscopy
Nieveen 1999 No diagnostic test accuracy data available for diagnostic laparoscopy
Nieveen 2000 No diagnostic test accuracy data available for diagnostic laparoscopy
Nieveen 2003 No diagnostic test accuracy data available for diagnostic laparoscopy
Nieveen 2003a No diagnostic test accuracy data available for diagnostic laparoscopy
Occelli 1999 No diagnostic test accuracy data available for diagnostic laparoscopy
Palanivelu 2001 Not a diagnostic accuracy study
Parks 2000 Not a diagnostic accuracy study
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Pedrazzoli 1994 No diagnostic test accuracy data available for diagnostic laparoscopy
Pelton 1998 Insufficient diagnostic test accuracy data available for diagnostic laparoscopy
Pietrabissa 1996 No diagnostic test accuracy data available for diagnostic laparoscopy
Pietrabissa 1996a No diagnostic test accuracy data available for diagnostic laparoscopy
Pietrabissa 1999 Includes participants who were considered to be unresectable by CT scan
Pisters 2001 Not a diagnostic accuracy study
Potkonjak 1974 No diagnostic test accuracy data available for diagnostic laparoscopy
Ramshaw 1999 Not a diagnostic accuracy study
Ribero 1994 No diagnostic test accuracy data available for diagnostic laparoscopy
Rodgers 2003 No separate data available for pancreatic or periampullary cancer
Rothlin 1996 Not a diagnostic accuracy study
Rumstadt 1997 No diagnostic test accuracy data available for diagnostic laparoscopy
Rumstadt 1997a No diagnostic test accuracy data available for diagnostic laparoscopy
Saeian 1999 Not a diagnostic accuracy study
Sand 1996 No separate data available for pancreatic or periampullary cancer
Santoro 2012 No information on whether the distant metastases were confirmed histologically as metastases
Sato 1985 Not a diagnostic accuracy study
Satoi 2011 No diagnostic test accuracy data available for diagnostic laparoscopy
Schachter 1999 Wrong target condition
Schmidt 1997 No diagnostic test accuracy data available for diagnostic laparoscopy
Schmied 2000 Not a diagnostic accuracy study
Schmielau 1997 Not a diagnostic accuracy study
Schneider 2003 The proportion of participants who were considered to be resectable after CT scan is not known
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Schnelldorfer 2014 Not clear whether histopathological confirmation of metastasis was obtained
Schrenk 1994 Number of participants with pancreatic or periampullary cancer was not reported
Schrenk 1995 No diagnostic test accuracy data available for diagnostic laparoscopy
Schwab 1996 Includes participants with unresectable cancers on CT scan
Sperlongano 2005 Not a diagnostic accuracy study
Sperlongano 2006 Not a diagnostic accuracy study
Tang 2001 No separate data available for pancreatic or periampullary cancer
Tapper 2011 No diagnostic test accuracy data available for diagnostic laparoscopy
Taylor 2001 No diagnostic test accuracy data available for diagnostic laparoscopy
Terrosu 2000 Number of participants with pancreatic or periampullary cancer was not reported
Thomson 2006 No diagnostic test accuracy data available for diagnostic laparoscopy
Tilleman 2004 Not a diagnostic accuracy study
Tilleman 2004a No diagnostic test accuracy data available for diagnostic laparoscopy
Toughrai 2013 Not a diagnostic accuracy study
van Delden 1996 No diagnostic test accuracy data available for diagnostic laparoscopy
van Dijkum 1997 The proportion of participants who were considered to be resectable after CT scan is not known
Velanovich 1998 No separate data available for pancreatic or periampullary cancer
Velanovich 2004 No diagnostic test accuracy data available for diagnostic laparoscopy
Velasco 2000 The proportion of participants who were considered to be resectable after CT scan is not known
Vollmer 2002 Includes participants who were considered to be unresectable by CT scan
Warshaw 1990 Not a diagnostic accuracy study
Warshaw 1990a Includes participants who were considered to be unresectable by CT scan
Watanabe 1993 No diagnostic test accuracy data available for diagnostic laparoscopy
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Weiner 1995 No separate data available for pancreatic or periampullary cancer
White 2001 Intervention between index test and reference standard
White 2004 Not a diagnostic accuracy study
White 2008 Wrong target condition
Wilson 2010 Not a diagnostic accuracy study
Yoshida 2002 No diagnostic test accuracy data available for diagnostic laparoscopy
Zhao 2003 No diagnostic test accuracy data available for diagnostic laparoscopy
CT: computed tomography
66Diagnostic accuracy of laparoscopy following computed tomography (CT) scanning for assessing the resectability with curative intent in
pancreatic and periampullary cancer (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
D A T A
Presented below are all the data for all of the tests entered into the review.
Tests. Data tables by test
Test
No. of
studies
No. of
participants
1 Diagnostic laparoscopy (all
studies)
16 1146
2 Diagnostic laparoscopy
(pancreatic cancer only)
7 340
Test 1. Diagnostic laparoscopy (all studies).
Review: Diagnostic accuracy of laparoscopy following computed tomography (CT) scanning for assessing the resectability with curative intent in pancreatic and peri-
ampullary cancer
Test: 1 Diagnostic laparoscopy (all studies)
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Ahmed 2006 9 0 4 24 0.69 [ 0.39, 0.91 ] 1.00 [ 0.86, 1.00 ]
Arnold 1999 11 0 4 18 0.73 [ 0.45, 0.92 ] 1.00 [ 0.81, 1.00 ]
Arnold 2001a 14 0 5 42 0.74 [ 0.49, 0.91 ] 1.00 [ 0.92, 1.00 ]
Beenen 2014 21 0 40 70 0.34 [ 0.23, 0.48 ] 1.00 [ 0.95, 1.00 ]
Brooks 2002 13 0 12 119 0.52 [ 0.31, 0.72 ] 1.00 [ 0.97, 1.00 ]
Contreras 2009 7 0 3 15 0.70 [ 0.35, 0.93 ] 1.00 [ 0.78, 1.00 ]
Fernandez-Castillo 1995 27 0 52 30 0.34 [ 0.24, 0.46 ] 1.00 [ 0.88, 1.00 ]
John 1995 14 0 14 12 0.50 [ 0.31, 0.69 ] 1.00 [ 0.74, 1.00 ]
Kishiwada 2002 10 0 0 6 1.00 [ 0.69, 1.00 ] 1.00 [ 0.54, 1.00 ]
Lavy 2012 5 0 9 38 0.36 [ 0.13, 0.65 ] 1.00 [ 0.91, 1.00 ]
Menack 2001 4 0 5 18 0.44 [ 0.14, 0.79 ] 1.00 [ 0.81, 1.00 ]
Merchant 1998 104 0 18 181 0.85 [ 0.78, 0.91 ] 1.00 [ 0.98, 1.00 ]
Reddy 1999 29 0 8 61 0.78 [ 0.62, 0.90 ] 1.00 [ 0.94, 1.00 ]
Reed 1997 2 0 7 2 0.22 [ 0.03, 0.60 ] 1.00 [ 0.16, 1.00 ]
Shah 2008 11 0 1 7 0.92 [ 0.62, 1.00 ] 1.00 [ 0.59, 1.00 ]
Warshaw 1986 14 0 3 23 0.82 [ 0.57, 0.96 ] 1.00 [ 0.85, 1.00 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
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Test 2. Diagnostic laparoscopy (pancreatic cancer only).
Review: Diagnostic accuracy of laparoscopy following computed tomography (CT) scanning for assessing the resectability with curative intent in pancreatic and peri-
ampullary cancer
Test: 2 Diagnostic laparoscopy (pancreatic cancer only)
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Ahmed 2006 9 0 4 24 0.69 [ 0.39, 0.91 ] 1.00 [ 0.86, 1.00 ]
Arnold 2001a 14 0 5 42 0.74 [ 0.49, 0.91 ] 1.00 [ 0.92, 1.00 ]
Contreras 2009 7 0 3 15 0.70 [ 0.35, 0.93 ] 1.00 [ 0.78, 1.00 ]
Fernandez-Castillo 1995 27 0 52 30 0.34 [ 0.24, 0.46 ] 1.00 [ 0.88, 1.00 ]
Kishiwada 2002 10 0 0 6 1.00 [ 0.69, 1.00 ] 1.00 [ 0.54, 1.00 ]
Lavy 2012 5 0 9 38 0.36 [ 0.13, 0.65 ] 1.00 [ 0.91, 1.00 ]
Warshaw 1986 14 0 3 23 0.82 [ 0.57, 0.96 ] 1.00 [ 0.85, 1.00 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
A D D I T I O N A L T A B L E S
Table 1. QUADAS-2 classification
Domain 1: Patient selection Patient sampling Patients with pancreatic and periampullary
cancer considered eligible for surgical re-
section following a CT scan
Was a consecutive or random sample of pa-
tients enrolled?
Yes: If a consecutive sample or a random
sample of patients with pancreatic and pe-
riampullary cancer eligible for surgical re-
section after CT scan was included in the
study
No: If a consecutive sample or a random
sample of patients with pancreatic and pe-
riampullary cancer eligible for surgical re-
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Table 1. QUADAS-2 classification (Continued)
section after CT scan was not included in
the study
Unclear: If this information was not avail-
able
Was a case-control design avoided? Yes: If a cohort of patients about to undergo
surgical resection were studied
No: If patients who underwent unsuccess-
ful laparotomy (cases) were compared with
patients who underwent successful surgical
resection (controls). Such studies were ex-
cluded
Unclear: We anticipated that we would be
able to determine whether the design was
case-control
As anticipated, we were able to determine
the study design andwere able to exclude all
case-control studies. So, all studies included
in this review were classified as ’yes’ for this
item
Did the study avoid inappropriate exclu-
sions?
Yes: If all patients with pancreatic and pe-
riampullary cancer eligible for surgical re-
section were included
No: If the study excluded patients based on
high probability of resectability (for exam-
ple, small tumours)
Unclear: If this information was not avail-
able
Could the selection of patients have intro-
duced bias?
Low risk of bias: If ’yes’ classification for
all the above 3 questions; high risk of bias:
if ’no’ classification for any of the above 3
questions; unclear risk of bias: if ’unclear’
classification for any of the above 3 ques-
tions but without a ’no’ classification for
any of the above 3 questions
Patient characteristics and setting Yes: We included only patients with pan-
creatic and periampullary cancer who were
considered eligible for surgical resection
following a CT scan. So, we anticipated all
the included studies to be classified as ’yes’
No: We excluded studies where patients
were considered unsuitable for surgery after
a CT scan. So, we did use this classification
Unclear: We excluded studies in which it
was not clear whether the patients had
undergone CT scan following which they
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Table 1. QUADAS-2 classification (Continued)
were still considered suitable for surgical re-
section
Are there concerns that the included pa-
tients and setting do not match the review
question?
Considering the inclusion criteria of this re-
view, we anticipated that all of the included
studies would be classified as ’low concern’.
However, this was not the case, as shown
in Figure 5
Domain 2: Index test Index test(s) Diagnostic laparoscopy with histologic
confirmation of metastases
Were the index test results interpretedwith-
out knowledge of the results of the refer-
ence standard?
The index test would always be conducted
and interpreted before the reference stan-
dard. So, this classification was always ’yes’
If a threshold was used, was it prespecified? Not applicable
Could the conduct or interpretation of the
index test have introduced bias?
We anticipated classifying all studies as
’low risk of bias’ because diagnostic la-
paroscopy indicates that structures within
the abdomen were inspected, diagnostic
laparoscopy would be conducted and in-
terpreted before reference standard, and
because we excluded any studies without
histological confirmation of the metastatic
spread
As anticipated, all of the studies were clas-
sified as ’low risk of bias’ for this domain
Are there concerns that the index test, its
conduct, or interpretation differ from the
review question?
Considering the inclusion criteria for this
review, we anticipated that all of the in-
cluded studies will be classified as ’low con-
cern’
As anticipated, all of the studies were clas-
sified as ’low concern’ for this domain
Domain 3: Target condition and refer-
ence standard
Target condition and reference standard(s) Unresectability. The reasons for unre-
sectability include involvement of adjacent
structures or distant metastases. There is
currently no universal criteria for unre-
sectability. Consensus exists for the def-
inition of borderline resectable cancers (
Abrams2009). Thereforewhere there is less
tissue involvement than in a borderline re-
sectable cancer, the tumour can be consid-
ered as resectable
Positive reference standard: Confirmation
of liver or peritoneal involvement by
70Diagnostic accuracy of laparoscopy following computed tomography (CT) scanning for assessing the resectability with curative intent in
pancreatic and periampullary cancer (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Table 1. QUADAS-2 classification (Continued)
histopathological examination of suspi-
cious (liver or peritoneal) lesions (irre-
spective of how the tissues were obtained
for histopathological examination). We ac-
cepted only paraffin section histology as the
reference standard. We also accepted the
surgeon’s judgement of unresectability on
laparotomy when biopsy confirmation was
not possible (e.g. the surgeon may not re-
sect the tumour if it invaded the adjacent
blood vessels but will not obtain a biopsy
confirmation of this because of the danger
posed by resecting a part of a large blood
vessel)
Negative reference standard: Cancer was
fully resected, i.e. clear resection margins
on histology
Is the reference standard likely to correctly
classify the target condition?
Yes: If histological confirmation of distant
spread or local infiltration of adjacent struc-
tures making the cancer unresectable was
obtained. The report on the resection mar-
gins showed clearly that the cancer was
completely resected. We did not anticipate
that any studies would meet these criteria
because of the danger that biopsy of infil-
tration of adjacent structures poses
No: If resection margins were not clear of
cancer
Unclear: If surgeon’s judgement was used
to assess unresectability or if the informa-
tion about the resection margins was not
available. We anticipated that most stud-
ies would be classified as ’unclear’ because
surgeon’s judgement is generally used as a
criterion for unresectability in clinical prac-
tice
As anticipated, all of the studies were clas-
sified as ’unclear’ for this item
Were the reference standard results inter-
preted without knowledge of the results of
the index tests?
It is not possible to perform the reference
standard without knowledge of the results
of the index test. However, only patients
with suspicious lesions on laparoscopy un-
dergo biopsy, and only patients with neg-
ative laparoscopy would undergo laparo-
tomy. The results of the index test are un-
likely to influence the results of the refer-
ence standard. All studies were classified as
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Table 1. QUADAS-2 classification (Continued)
’no’ for this question
Could the reference standard, its conduct,
or its interpretation have introduced bias?
Risk of bias was determined as ’low’ if the
answer to the first question was ’yes’, ’high’
if the answer to the first question was ’no’,
and ’unclear’ if the answer to the first ques-
tion was ’unclear’
Are there concerns that the target condition
as defined by the reference standard does
not match the question?
Considering the inclusion criteria for this
review, we anticipated that all of the in-
cluded studies would be classified as ’low
concern’
As anticipated, all of the studies were clas-
sified as ’low concern’ for this domain
Domain 4: Flow and timing Flow and timing The cancer may progress if there is
long time interval between diagnostic la-
paroscopy and laparotomy. So, we chose an
arbitrary time interval of 2 months as an
acceptable time interval between diagnos-
tic laparoscopy and laparotomy
Was there an appropriate interval between
index test and reference standard?
Yes: If the time interval between diagnostic
laparoscopy and laparotomy was less than
2 months
No: If the time interval between diagnostic
laparoscopy and laparotomywasmore than
2 months
Unclear: If the time interval between diag-
nostic laparoscopy and laparotomy was un-
clear
Did all patients receive the same reference
standard?
Yes: If all of the patients received the same
reference standard (we anticipated that all
the studies would be classified as ’yes’)
No: If different patients received different
reference standards
Unclear: If this information was not clear
Were all patients included in the analysis? Yes: If all of the patients were included in
the analysis irrespective of whether the re-
sults were uninterpretable
No: If some patients were excluded from
the analysis because of uninterpretable re-
sults
Unclear: If this information was not clear
Could the patient flow have introduced
bias?
Low risk of bias: if ’yes’ classification for all
of the above 3 questions; high risk of bias:
if ’no’ classification for any of the above 3
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Table 1. QUADAS-2 classification (Continued)
questions; unclear risk of bias: if ’unclear’
classification for any of the above 3 ques-
tions but without a ’no’ classification for
any of the above 3 questions
CT: computed tomography
Table 2. Prior testing and unresectability
Study name Type of CT scan Prior testing in
addition to CT
scan
Prob-
ability of CT re-
sectable disease
identified as un-
resectable by di-
agnostic la-
paroscopy or la-
parotomy
(Pre-test proba-
bility)
Number of par-
ticipants
(N) and reasons
for CT re-
sectable disease
identified as un-
resectable by di-
agnostic
laparoscopy
Prob-
ability of CT
and diagnostic
laparoscopy re-
sectable disease
identified as un-
resectable at la-
parotomy
(Post-test prob-
ability of neg-
ative diagnostic
laparoscopy)
Number of par-
tic-
ipants (N) and
reasons for CT
and diagnostic
laparoscopy re-
sectable disease
identified as un-
resectable at la-
parotomy
Ahmed 2006 Helical CT scan None described 35.1 N = 9
Liver metastases
= 6
Peritoneal
metastases = 1
Peritoneal and
liver metastases =
2
14.3 N = 4
Metastatic
disease = 2
Locally
advanced disease
(1 coeliac artery
lymph
node, 1 mesen-
teric vascular in-
volvement) = 2
Arnold 1999 No further infor-
mation on CT
scan was avail-
able
All par-
ticipants under-
went endoscopy
and ultrasound.
Some partici-
pants underwent
EUS, proportion
unclear
45.5 N = 11
Liver metastases
= 6
Peritoneal
metastasis = 1
Peritoneal and
liver metastases =
3
Peritoneal and
omental metas-
tases = 1
18.2 N = 4
Liver metastases
= 2
Peritoneal
metastases = 1
Liver and peri-
tonealmetastases
= 1
Arnold 2001 No further infor-
mation on CT
scan was avail-
Endoscopy,
ultrasound,
and MRI. Pro-
31.1 N = 14
Liver metastases
= 8
10.6 N = 5
Liver metastases
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Table 2. Prior testing and unresectability (Continued)
able portion of par-
ticipants who re-
ceived
each modality is
unclear
Peritoneal
metastases = 2
Liver and peri-
tonealmetastases
= 4
= 3
Peritoneal
metastases = 2
Metastases in the
omentum and
mesocolon = 2
Some had spread
to more than 1
location
Beenen 2014 No further infor-
mation on CT
scan was avail-
able
All par-
ticipants under-
went abdominal
ultrasound and
ERCP
46.6 N = 21
Reasons for un-
resectability not
stated
36.3 N = 40
Reasons for un-
resectability not
stated
Brooks 2002 Con-
trast enhanced,
thin slice
85% of partici-
pants underwent
ERCP
17.4 N = 13
Liver metastases
= 6
Peritoneal
metastases = 5
Other metastatic
disease = 2
9.2 N = 10
Liver metastases
= 3
Vascular
invasion = 3
Peritoneal
metastases = 1
Local extension
= 1
Benign disease =
2
Contreras 2009 Pancreas proto-
col CT scan
EUS used
in some partic-
ipants, propor-
tion unclear
40.0 N = 7
Liver metastases
= 4
Peritoneal
metastases = 2
Gross regional
lymphadenopa-
thy = 1
16.7 N = 3
Aortocaval node
disease = 1
Liver metastases
= 1
Coeliac node
disease = 1
Fernandez-
Castillo 1995
Further details
not known
None described 72.4 N = 27
Liver metastases
= 11
Peritoneal
metastases = 3
Omental metas-
tases = 2
Metastases in
more than 1 site
= 11
63.4 N = 87
Vascular in-
vasion at subse-
quent angiogra-
phy and did not
undergo laparo-
tomy = 42
Peritoneal
disease at laparo-
tomy = 2
Reasons
for unresectabil-
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Table 2. Prior testing and unresectability (Continued)
ity at laparotomy
not stated = 43
John 1995 Contrast-en-
hanced dynamic
CT scan
Various scanning
techniques used.
Exact techniques
and pro-
portion who re-
ceived themwere
unclear
70.0 N = 14
Liver metastases
= 10
Peritoneal
metastases = 8
Hilar
lymph node in-
volvement = 2
Some had spread
to more than 1
location
53.8 N = 14
Metastatic
disease = 2
Locally
advanced and
metastatic
disease = 1
Locoregional
spread = 11
Kishiwada 2002 Helical CT scan All participants
received
ultrasound
62.5 Reasons for un-
resectability not
stated
0 Reasons
for unresectabil-
ity at laparotomy
not stated
Lavy 2012 No further infor-
mation on CT
scan was avail-
able
All participants
received EUS
26.9 Peritoneal
metastases = 5
19.1 N = 9
Metastatic
disease = 2
Locally ad-
vanced cancer =
7
Menack 2001 Contrast-en-
hanced CT scan
with thin slices
of pancreas
Transabdom-
inal ultrasound,
EUS, and ERCP
performed
in some partic-
ipants, propor-
tion unclear
33.3 Reasons for un-
resectability not
stated
21.7 N = 5
Portal vein oc-
clusion = 1
Metastatic dis-
ease in the lymph
nodes or liver
on laparoscopic
ultrasound and
biopsy = 2
Portal vein en-
casement = 1
Locally ad-
vanced disease at
laparotomy = 1
Merchant 1998 Further details
not known
Ul-
trasound, ERCP,
and angiography
performed
on some partic-
ipants, propor-
tion unclear
40.3 N = 104
Liver metastases
= 48
Extrapancreatic
spread = 41
Nodal spread =
20
9.0 N = 18
Liver metastases
= 6
Extrapancreatic
disease = 3
Positive nodal
disease = 3
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Table 2. Prior testing and unresectability (Continued)
Vascular
invasion = 37
Some had spread
to more than 1
location
Vascular
invasion = 2
Benign disease =
4
Reddy 1999 Further details
not known
None described 37.8 N = 29
Liver metastases
= 23
Liver and peri-
tonealmetastases
= 3
Hep-
atic, peritoneal,
and mesenteric
metastases = 1
Mesenteric
involvement = 2
11.6 N = 6
Liver metastases
= 4
Peripancre-
atic lymph node
involvement = 2
Reed 1997 Further details
not known
None described 81.8 Reasons for un-
resectability not
stated
77.8 N = 7
Local tumour
spread = 5
Omental spread
= 1
Unclear = 1
Shah 2008 Multi-
detector row CT
using pancreatic
protocol
None described 63.2 N = 9
Metastases = 6
Locally
advanced disease
= 3
12.5 Liver metastasis
= 1
Warshaw 1986 Further details
not known
All participants
received chest
roentgenogra-
phy, transhepatic
cholangiog-
raphy, or ERCP
and
abdominal ultra-
sound. Some re-
ceived
coeliac and supe-
rior mesenteric
angiography
42.5 N = 14
Liver metastases
= 6
Parietal peri-
tonealmetastases
= 7
Omental
metastatic
disease = 1
11.5 Liver metastases
= 3
CT: computed tomography
DL: diagnostic laparoscopy
ERCP: endoscopic retrograde cholangio-pancreatography
EUS: endoscopic ultrasound
76Diagnostic accuracy of laparoscopy following computed tomography (CT) scanning for assessing the resectability with curative intent in
pancreatic and periampullary cancer (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
MRI: magnetic resonance imaging
All probabilities in the table are reported as percentages.
A P P E N D I C E S
Appendix 1. Glossary of terms
Index test: The diagnostic test being evaluated. In this review the index test is diagnostic laparoscopy after CT scanning
QUADAS: A tool for assessing the methodological quality of diagnostic accuracy studies in terms of risk of bias and applicability to
the review question. The assessment parameters are described in more detail in the main text of the review
Reference standard: The test that is accepted as the best available to classify the target condition correctly in a particular setting. In this
review the reference standard is biopsy with histopathological confirmation after diagnostic laparoscopy or laparotomy, or the surgeon’s
judgement of unresectability at laparotomy when biopsy confirmation was not possible
Sensitivity: Proportion of diseased individuals correctly identified as having the disease by the index test i.e. True positives/(True
positives + False negatives)
Specificity: Proportion of disease-free individuals correctly identified as being disease-free by the index test i.e. True negatives/(False
positives + True negatives)
Target condition: The disease or condition to be diagnosed. In this review the target condition is unresectable pancreatic and peri-
ampullary cancer
Appendix 2. Cochrane Register of Diagnostic Test Accuracy Studies and CENTRAL search strategy
#1 ((ampulla near/2 vater*) or ampullovateric or (papilla near/2 vater*) or periampulla* OR peri-ampulla* OR choledoch* or alchole-
doch* or bile duct* or biliary or cholangio* or gall duct or duoden* or small bowel or small intestin* or enter* or pancrea*)
#2 (carcin* or cancer* or neoplas* or tumour* or tumor* or cyst* or growth* or adenocarcin* or malign*)
#3 (#1 AND #2)
#4 (pancreatect* OR pancreaticojejunost* OR pancreaticogastros* OR pancreaticoduodenect* OR duodenopancreatectom*)
#5 (#3 OR #4)
#6 (laparoscop* or peritoneoscop* or celioscop* or coelioscop*)
#7 (#5 AND #6)
Appendix 3. MEDLINE search strategy
(((((ampulla vateri[tiab] OR “Ampulla of Vater” [Mesh] OR ampullovateric[tiab] OR papilla vateri[tiab] OR vater papilla[tiab] OR
vater ampulla[tiab] OR peri-ampull*[tiab] OR periampull*[tiab] OR choledoch*[tiab] OR alcholedoch*[tiab] OR bile duct*[tiab] OR
biliary[tiab] OR cholangio*[tiab] OR gall duct[tiab] OR duodenum[tiab] OR duodenal[tiab] OR duoden*[tiab] OR small bowel[tiab]
OR small instestin*[tiab] OR enteral[tiab] OR enteric[tiab] OR enter*[tiab] OR pancreatic[tiab] OR pancreato*[tiab] OR pan-
creas*[tiab]) AND (carcinoma[tiab] OR carcinomas[tiab] OR carcin*[tiab] OR cancer*[tiab] OR neoplas*[tiab] OR tumor[tiab] OR
tumors[tiab] OR tumorous[tiab] OR tumour*[tiab] OR tumor*[tiab] OR cyst[tiab] OR cysts[tiab] OR cystic[tiab] OR cyst*[tiab]
OR growth*[tiab] OR adenocarcin*[tiab] OR malignant[tiab] OR malignancy[tiab])) OR “Duodenal Neoplasms”[Mesh] OR “Pan-
creatic Neoplasms”[Mesh] OR “Common Bile Duct Neoplasms”[Mesh]) AND (surger*[tiab] OR operat*[tiab] OR resection*[tiab]
OR surgical*[tiab] OR Surgical Procedures, Operative[MeSH] OR General Surgery[MeSH])) OR (pancreatect*[tiab] OR pancreati-
cojejunost*[tiab] OR pancreaticogastros*[tiab] OR pancreaticoduodenect*[tiab] OR duodenopancreatectom*[tiab] OR Pancreatec-
tomy[MeSH] OR Pancreaticojejunostomy[MeSH] OR Pancreaticoduodenectomy[MeSH])) AND (laparoscop*[tiab] OR peritoneo-
scop*[tiab] OR celioscop*[tiab] OR coelioscop*[tiab] OR “Laparoscopy”[Mesh])
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Appendix 4. EMBASE search strategy
1 ((ampulla vateri or ampullovateric or papilla vateri or vater papilla or vater ampulla or periampull* or peri-ampull* or choledoch* or
alcholedoch* or bile duct* or biliary or cholangio* or gall duct or duoden* or small bowel or small intestin* or enter* or pancrea*) and
(carcin* or cancer* or neoplas* or tumour* or tumor* or cyst* or growth* or adenocarcin* or malign*)).ti,ab.
2 exp duodenum cancer/ or Vater papilla tumor/ or exp pancreas cancer/ or exp bile duct tumor/
3 1 or 2
4 (surger* or surgical* or operat* or resection*). ti,ab.
5 exp Surgery/
6 4 or 5
7 3 and 6
8 (pancreatect* OR pancreaticojejunost* OR pancreaticogastros* OR pancreaticoduodenect* OR duodenopancreatectom*). ti,ab.
9 exp pancreas surgery/
10 7 or 8 or 9
11 (laparoscop* or peritoneoscop* or celioscop* or coelioscop*). ti,ab.
12 laparoscopy/ or laparoscopic surgery/
13 11 or 12
14 10 and 13
Appendix 5. Science Citation Index search strategy
#1TS=(((ampulla vateri or ampullovateric or papilla vateri or vater papilla or vater ampulla or periampull* or peri-ampull* or choledoch*
or alcholedoch* or bile duct* or biliary or cholangio* or gall duct or duoden* or small bowel or small intestin* or enter* or pancrea*)
and (carcin* or cancer* or neoplas* or tumour* or tumor* or cyst* or growth* or adenocarcin* or malign*)))
#2 TS=(operat* OR surger* OR surgical* OR resection*)
#3 #1 AND #2
#4 TS=(pancreatect* OR pancreaticojejunost* OR pancreaticogastros* OR pancreaticoduodenect* OR duodenopancreatectom*)
#5 #3 OR #4
#6 TS=(laparoscop* or peritoneoscop* or celioscop* or coelioscop*)
#7 #5 AND #6
Appendix 6. SAS code for analysis
data DiagnosticTestMetaAnalysis;
input Study˙id TP FP FN TN;
datalines;
1 9 0 4 24
2 11 0 4 18
3 14 0 5 42
4 21 0 40 70
5 13 0 12 119
6 7 0 3 15
7 27 0 52 30
8 14 0 14 12
9 10 0 0 6
10 5 0 9 38
11 4 0 5 18
12 104 0 18 181
13 29 0 8 61
14 2 0 7 2
15 11 0 1 7
16 14 0 3 23
78Diagnostic accuracy of laparoscopy following computed tomography (CT) scanning for assessing the resectability with curative intent in
pancreatic and periampullary cancer (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
run;
/* Modify the dataset for the analysis */
data dt;
set DiagnosticTestMetaAnalysis;
sens=1; spec=0; true=tp; n=tp+fn; output;
sens=0; spec=1; true=tn; n=tn+fp; output;
run;
/* Ensure that both records for a study are clustered together */
proc sort data=dt;
by study˙id ;
run;
ods output ParameterEstimates=pet4 FitStatistics=fitt4 additionalestimates=addest4;
/* Run random effects logistic regression model for sensitivity only*/
proc nlmixed data=dt tech=quanew lis=5 qpoints=10;
parms msens=2 s2usens=0 ;
logitp=(msens+usens)*sens;
p = exp(logitp)/(1+exp(logitp));
model true ~ binomial(n,p);
random usens ~ normal([0],[s2usens]) subject=study˙id out=randeffs;
/* logLR based on spec=1 */
estimate ’logLR-’ log((1-(exp(msens)/(1+exp(msens))))) ;
run;
/* Obtain summary sens and spec from the model 4 */
data summary4;
set pet4;
if parameter = ’msens’ then name = ’Sensitivity’;
if parameter = ’msens’ then summary=100 * exp(estimate)/(1 + exp(estimate));
if parameter = ’msens’ then summlower=100 * exp(lower)/(1 + exp(lower));
if parameter = ’msens’ then summupper=100 *exp(upper)/(1 + exp(upper));
output;
run;
/* Obtain summary LR- */
data summaryLR;
set addest4;
summary=exp(estimate);
summlower=exp(lower);
summupper=exp(upper);
output;
run;
Appendix 7. Calculation of post-test probability of unresectable disease for patients with a negative
test result
The post-test probability of unresectable disease for patients with a negative test result can be calculated from the pre-test probability of
unresectable disease and the negative likelihood ratio. The calculation using the median pre-test probability from the included studies,
as an example, is shown below.
Pre-test probability = 0.414
Pre-test odds = Pre-test probability/(1 - Pre-test probability) = 0.414/0.586 = 0.706
Post-test odds of negative test = Post-test odds * negative likelihood ratio = 0.706 * negative likelihood ratio
Post-test probability of unresectable disease for patients with a negative test result = Post-test odds/(1 + Post-test odds)
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